(1 day, 23 hours ago)
Lords ChamberMy Lords, I am grateful for the debate that we have had on these amendments and the points that have been put forward. I will address the amendments together as well as, indeed, focusing on the Health Bill. I make that point as I am about to turn first to Amendment 279QP tabled by the noble Baroness, Lady Cass, and spoken to by the noble Lord, Lord Singh; and my noble friend Lord Hunt also made reference, as did other noble Lords, to matters relating to the conversion practices Bill. I am grateful to the noble Lord, Lord Scriven, for speaking about his involvement in this matter. Of course, as the noble Lord was referring to, that Bill is subject to pre-legislative scrutiny, to which noble Lords are welcome to contribute and I certainly hope that that they will do.
My noble friend Lord Hunt and the noble Baroness, Lady Barker, spoke in particular to the point that children and young people who are questioning their gender identity deserve compassionate care that takes account of their individual needs and circumstances. That is a duty upon the health service as well as upon all of us.
Your Lordships’ House will know that this Government, working in full partnership with NHS England, are continuing to implement the findings and the recommendations of the review, conducted by the noble Baroness, Lady Cass, of the NHS Children and Young People’s Gender Service, which was commissioned during the term of the previous Government. I am grateful to the noble Baroness, Lady Cass, for both her previous work and her continuing work, as well as for the clarity that she brings to this matter.
I will speak to the noble Baroness’s points about standards for gender services, which are key. Since the review’s publication in 2024, four new regional services are providing holistic care, centered on psychosocial support. They have opened and are seeing patients on the waiting list. In April, as the noble Baroness will of course be aware, NHS England published the new service specification. I am, perhaps, saying this more for the benefit of your Lordships’ House than that of the noble Baroness herself, but I think it is worth reminding ourselves. This requires the services to use the Cass review’s holistic assessment framework and to train clinical staff using a standard professional competence framework designed by the Academy of Medical Royal Colleges. All clinicians working in the NHS Children and Young People’s Gender Service must follow the service specification.
I turn now to Amendment 75, moved by the noble Baroness, Lady Davies. May I say, as she did refer to it, how sorry I am, as I am sure the whole House is, to hear of the circumstances of the death of her mother, about which she spoke before the break. I can tell the noble Baroness that the national review of adult gender services, chaired by Dr David Levy, was published in December last year. It marks a significant step forward in our commitment to improving gender dysphoria services across the NHS.
The noble Lord, Lord Scriven, asked about accountability. As we have discussed in earlier groups, Ministers—in particular, the Secretary of State—are accountable to Parliament, including for these services. The point about the commissioning of these services is of interest to my noble friend Lord Hunt as well. Again, as I confirmed in an earlier group, we anticipate being able to share the list of specialised nationally commissioned services before Report. We are not expecting a great change from what we currently have.
We have publicly committed to implementing the findings and recommendations of the review chaired by Dr David Levy, and the Department of Health and Social Care is working in full partnership with NHS England, which will include the publication of an updated national service specification, as I have mentioned, for adult gender services.
If I had to emphasise one point, it would be that the abolition of NHS England will not impact the work to improve adult gender services. We have made public commitments on the implementations of reviews and recommendations, and that will not change. Effective governance is indeed in place.
The noble Baroness, Lady Davies, referred to the WellBN GP practice. Again, I put on the record that when I talk about the “care” provided by that GP practice, I mean that it was totally unacceptable, and we are working to ensure that those affected are properly supported. I say to all noble Lords that for children and young people with gender dysphoria, and for their safety and well-being, any action taken will always be led by clinical evidence.
On Amendment 275, also in the name of the noble Baroness, Lady Davies, good progress has already been made towards delivering the data linkage study that is referenced in the amendment and was recommended by the noble Baroness, Lady Cass, in her review. On 20 March, an order made by the Secretary of State under Section 22 of the Gender Recognition Act 2004 came into force. That order facilitates lawful data sharing as part of the study, and I am pleased that the Health Research Authority has now improved the study. NHS England has undertaken further positive engagement with data-sharing partners and expects all commissioned adult gender services to collaborate, which is a different situation from what has existed. NHS England will also publish patient information materials shortly, marking the formal launch of the study. Study findings, reported on an aggregated and anonymised basis, will be published once the analysis is complete, and the study forms part of a wider programme of research, again as recommended in the Cass review. As is the case for all publicly funded research, all studies will adhere to ethical data and legal requirements.
On Amendment 276 in the name of the noble Baroness, Lady Davies, the independent Cass review and the NHS review of adult gender services recommended that NHS England should ensure that there is provision for people who are considering detransition. NHS England is acting on those recommendations by developing a clinical pathway for detransition services, and the department will support this work after abolition. It is therefore our view that the amendment is not necessary.
I remind your Lordships’ House that there is very limited evidence to inform this work. NHS England held a call for evidence last year, and a description of a proposed clinical pathway and detransition service will be shared for stakeholder engagement as soon as it is possible to do so in advance of a public consultation. That is likely to include proposals for improving the evidence base through data collection, research activities and clinical audit.
Lastly, on Amendment 279QQ in the name of the noble Baroness, Lady Cash, Section 62 of the Medicines Act 1968 allows the Secretary of State to restrict the sale and supply of medicines where it is necessary to protect patients’ safety. It is a significant order that has been used sparingly. Except in an emergency, that law requires consultation with relevant parties and advice from the independent expert body before restrictions are introduced. Those safeguards are to protect patients and to inform the decision of the Secretary of State. The amendment would require the Secretary of State to introduce restrictions for particular drugs used for a particular purpose, and it would remove the opportunity to consult independent expert advice before deciding whether those restrictions were needed. I therefore hope the noble Baroness will understand our reservations about the amendment.
The noble Baroness, Lady Cash, went to considerable lengths to say that there was extensive consensus. Not entirely: I do not accept some of the arguments she deployed. “Praying away the gay” is a line that regularly comes from anti-trans organisations that pretend to be LGB protection organisations but are in fact out to pursue a number of different strategies that are anti-trans.
If the amendment from the noble Baroness, Lady Cash, went through and there was no improvement in access to hormones via the NHS, that would be tantamount to preventing people transitioning. That would be a material effect. The noble Baroness, Lady Cass, looked at that danger in relation to children. She was concerned about the non-availability of hormones and people getting them from other sources because they could not get them from the NHS. Does the Minister understand that the proposal from the noble Baroness, Lady Cash, has to be taken in the context of the improved service that she is talking about?
I understand the point that the noble Baroness, Lady Barker, is making. I could make a number of points on masculinising and feminising hormones, but the point raised particularly by the noble Lord, Lord Scriven, and the noble Baroness, Lady Cash, was about unsafe online and international prescriptions. The General Pharmaceutical Council, the CQC and the Medicines and Healthcare products Regulatory Agency have powers to investigate and act. They have our full support. I should add that last year we sought evidence on private prescribing, including online services and medicines obtained from prescribers in the European Economic Area. We are looking at the responses before deciding on next steps, because we recognise the concerns of the noble Baroness and the noble Lord.
The noble Lord, Lord Scriven, asked about the order made in February this year for the study under the Gender Recognition Act. I can confirm that we are confident the order provides the necessary legal protections to facilitate the sharing of data required for the study.
Baroness Davies of Devonport (Con)
I thank the Minister and all noble Lords for their contributions today. The least we must expect from our National Health Service is evidence-based medicine and mandatory data collection, so that we can base that evidence on data we have collected that is mandatory and correct. Our children cannot be yet another live experiment, particularly vulnerable young children with complex needs. We have had several experiments over the last few decades, and the cover-up has always been worse than the original sin; it is really important that we have transparency and accountability. Historically, up to 2010, 80% of children who identified as transgender, if allowed to go through puberty with watchful waiting, desisted. A large majority of those were same-sex attracted. Puberty is not an illness; we must not treat it as such.
On funding, the only funding I have ever seen is women crowdfunding to fight their cases to protect their female-only spaces. I would like to add one little thing about the experiment. I was competing with East Germans during the 1970s and 1980s. Those young women were given testosterone all the way through puberty. Every single one of those young girls is sick or ill, or died or had disabled children. We have done this experiment. Please stop pretending we have never done it before, because that is not true. With that, I echo the comments made by the noble Baroness, Lady Cash, and the noble Lord, Lord Singh, and I welcome the comments made by the noble Baroness, Lady Cass, on the unworkable conversion Bill. I beg leave to withdraw my amendment.
I promise the noble Baroness that I will not turn it off.
I am grateful to all noble Lords who spoke in this debate, raising important questions about how integrated care boards draw upon the expertise and experience across our health and care system. I am sure that there is little disagreement among noble Lords about the valuable contribution made by allied health professionals, primary care practitioners, some public health specialists, paediatric experts and those working in secondary care. It is quite clear that effective partnerships will be essential if we are to deliver genuinely integrated services that meet the needs of patients and communities. I completely understand the motivation behind these amendments and the desire to ensure that important voices are heard within local decision-making structures.
The amendments from my noble friend Lord Lansley, spoken to by my noble friend Lord Redwood, prompt us to consider whether our future arrangements adequately reflect the changing landscape of local and regional governance. For that reason, they are valuable amendments.
There is a legitimate question about how far Parliament should go in prescribing the precise membership of integrated care boards, as spoken to by a number of noble Lords. One of the arguments advanced when integrated care boards were established—I remember this well from discussions on the Health and Care Bill in 2022—was that local leaders should be given greater freedom to organise services around the needs of their populations. There is a risk that, with every additional statutory requirement, we move further away from that principle. So one of the tensions in this Bill is that we want better local decision-making and to move from hospital to community but, at the same time, as identified by the noble Lord, Lord Scriven, we have Clause 11.
I turn back to the Health and Care Bill. Noble Lords who remember that—whether fondly or not—will know that almost every sector lobbied to have their representative on the integrated care board or integrated care partnership. In the end, both the Government at the time and the Opposition agreed that including everyone would lead to unwieldy integrated care boards. The compromise we made at the time was something like “to have due regard to”. Many felt that that was too weak, and we still have not resolved the tension between having regard to various experts and, at the same time, making sure that integrated care boards are not unwieldy.
We have to acknowledge—and I do not know how we challenge this—the hierarchies that exist. At the ICB level, there is no doubt that they are often dominated by the large trusts and that other voices struggle to be heard. At the primary care level, often it is GPs who dominate, and others, such as pharmacists or optometrists, may struggle or feel left out by the GPs seeking to represent all primary care. It just shows that there is so much granularity at that level, but we cannot put them all on the integrated care board. On top of that is the point made by the noble Lord, Lord Scriven, that, even if we did get them all on the integrated care boards, the Secretary of State could, with a swipe of a pen, decide that it is all irrelevant.
While I am sympathetic to the objectives of many of these amendments, these Benches remain cautious about placing ever more detailed governance requirements in primary legislation, especially given the tension that would be created by insisting that the Bill provides for specific expertise on integrated care boards, which would leave us with unwieldy boards, recognising that we still have not resolved the issue and made sure that all voices are heard. This is why, like the noble Baroness, Lady Pidgeon, I am hoping that the Minister will be able to shine a light and help us out, and show us the way.
I will do my best, and your Lordships can be the judge.
I am grateful to noble Lords for teasing out a number of the challenges. I am particularly grateful to the noble Lord, Lord Kamall, for taking us back to past discussions and the tensions there are. That is realistic about where we are starting from.
The noble Lord, Lord Scriven, made broad remarks that, in his view, the amendments are irrelevant for the reasons that he explained to do with the Secretary of State’s powers. I take us back to the discussion we had last week and re-emphasise to noble Lords that we expect the Secretary of State—and all future Secretaries of State—to use the power of direction proportionately. I have every confidence that that will happen. The whole point about putting things in primary legislation is to guide all Secretaries of State about expectation, no matter who they are.
Amendments 81, 84 and 107, tabled by the noble Lord, Lord Lansley, were introduced by the noble Lord, Lord Kamall, and spoken to by the noble Lord, Lord Redwood. As set out in the Rewiring the State statement, the Government will not impose mayors on areas that do not want one. We consider that directly accountable mayors represent the strongest form of governance available. It is right that we make statutory provision for mayoral nominees to sit on ICBs, as areas with mayors will have greater powers available to them.
That said, we recognise the variation in devolution arrangements across England. I want to reassure noble Lords that, for areas without mayors, we will set out in guidance that ICBs should make appropriate provision for board members nominated by those authorities. I expect this to promote collective action, including on the wider determinants of health. We need to bear in mind that directly set out health and social care matters are not always the only determinants of health, as we have discussed a number of times; those wider determinants are so key in driving health outcomes and demand.
I understand the points about local representation and expertise. That is why, having heard those concerns in the other place, we amended the Bill to restore the requirement that every ICB includes a local authority member, jointly nominated by the relevant upper tier local authorities. I hope that is helpful.
While I am dealing with this, I will pick up the point from my noble friend Lord Bradley, who had such confidence that I would be able to simplify an answer to his question. I will be pleased to write to him and place a copy in the Library to unpickle all the points he made.
I turn to Amendment 82, tabled by the noble Baroness, Lady Pidgeon, on primary care service providers; Amendment 81A, tabled by the noble Baroness, Lady Finlay, on allied health professionals, which my noble friend Lord Bradley and others spoke to; and Amendment 83, tabled by the noble Lord, Lord Patel, on directors of public health. Although it is our view that we do not feel it necessary to amend ICB membership requirements, I agree with noble Lords on how essential clinical leadership is to effective commissioning. That is why every ICB is required to have appropriate clinical leaders as board members—typically, a medical director and nursing director. In addition—I hope this will be helpful on a number of the points raised—ICBs should ensure that expertise, including that of primary care, allied health professionals and directors of public health, is embedded within ICB decision-making. I emphasise that, where relevant, as it will be increasingly, that expertise should also support work around neighbourhood health.
The noble Lord, Lord Kamall, spoke to the reassurance that I want to give your Lordships: we believe in the importance of local flexibility. That is why it is within the gift of ICBs to make provision for membership and participation as they deem appropriate within their structures. That said, they have a duty to keep the membership of their boards under review to ensure the necessary expertise and experience. It is also important that boards are effective decision-makers, which is why we are removing providers from ICB boards, in line with our commitment to simplify and focus NHS accountability.
On Amendment 87, tabled by the noble Baroness, Lady Pidgeon, and spoken to by the noble Lord, Lord Patel, and the noble Baroness, Lady Gerada, we have retained the requirement for an ICB to engage with its system partners in the exercise of its planning and commissioning activities, including providers of primary care services. Full engagement with providers, including primary care, is universally recognised as fundamental to good commissioning. That is the job of an ICB, as is reflected in the strategic commissioning framework.
ICBs will continue to engage local representative primary care committees. They must also comply with their duty to obtain appropriate advice from persons who have a broad range of professional expertise in the prevention, diagnosis or treatment of illness and the protection or improvement of public health. I hope that will be helpful to a number of noble Lords.
My Lords, I welcome the debate we have just had on this group. I will start by noting the points about the Bill in general. I have heard the observations and points that noble Lords have made about the Bill, particularly in respect of devolution and the change of Prime Minister to Andy Burnham. It is not our view that the Bill conflicts with rewiring the state. This legislation has the flexibility to support devolution, which is not a one-off but rather a continuing process, as we have discussed before. However, I will of course reflect on the points that noble Lords have made.
I turn to the Clause 24 stand part notice and Amendments 85, 94 and 210. Clause 24 abolishes the requirement for ICBs and their partner local authorities to form an integrated care partnership. It also abolishes the related requirement for this partnership to prepare and publish an integrated care strategy. I understand the concerns that noble Lords have raised, but these provisions address policy objectives of the 10-year health plan by streaming the number of plans that local health systems are required to produce and supporting local stakeholders to work together more flexibly and effectively —exactly what noble Lords are seeking. The changes recognise that, in many areas, integrated care partnerships have not had the expected impact on local health outcomes and come with significant opportunity costs. However, I assure your Lordships’ Committee that, where existing arrangements are working well, there is nothing in the Bill that prevents local areas continuing to come together to consider how best to integrate services and plan their approach to tackling the challenges they face. As we know, those challenges will vary according to locality.
On Amendment 85, I am grateful to my noble friend Lord Hunt for bringing forward a discussion on women’s health centres and the join-up between health and social care. Regarding women’s health centres in particular—spoken to by my noble friends Lord Bradley and Lady Royall of Blaisdon—the existing duties already require integrated care boards to reduce inequalities and, to the point made by the noble Lord, Lord Kamall, to involve the public and voluntary sector partners in planning and commissioning. We have reinforced this through the Renewed Women’s Health Strategy and the NHS 10-year health plan. In both of these, as noble Lords will be aware, tackling inequalities is absolutely key. Additionally, we are prioritising the most disadvantaged areas and the most disadvantaged groups, rather than starting the other way around, which has happened in the past. We are walking towards the challenge, rather than away from it.
The women’s health strategy has value way beyond health. It certainly goes into criminal justice, as my noble friend Lord Hunt referred to, and into the drivers of inequality. On how to work with community-based organisations in respect of women’s centres, raised by my noble friend Lord Bradley, there will be a period of design and engagement. Following that, we will set up a women’s voice partnership, through which we will very much focus on the organisations my noble friends have given examples of—those that represent the women who are most excluded from traditional services. I would absolutely expect women who are in contact with the criminal justice system, or who are in danger of doing so, to come into that category. The women’s voice partnership will allow the informing of decision-making and, over time, regional planning and delivery. We are looking to change how we are doing things and making sure that the most unheard women’s voices will be heard.
However, the amendment mandates a statutory relationship with women’s centres. We feel that this risks reducing the flexibility ICBs need to design services around local needs and existing partnerships. I can certainly give the assurance, as outlined in the Renewed Women’s Health Strategy, that the role of women’s centres and women’s health hubs that the noble Baroness, Lady Finlay, spoke to is absolutely key. They are a model of prevention work and of neighbourhood healthcare and support, and I hope they will inspire other areas.
Turning to Amendment 210, we are strengthening the join-up of healthcare and social care so that people can experience more integrated and person-centred care via the development of neighbourhood health. As the Cabinet statement Rewiring the State sets out, co-operation at local level remains key to success to ensure that services work together as a single coherent system built around the priorities people have. There were questions and debate in this group about the relationship between health and local government. I re-emphasise that the Bill simplifies a rather complex legal framework, to put it mildly. In the future, as we have debated earlier, health and wellbeing boards will be the focal point for collaboration between the NHS and local authorities, to support locally led neighbourhood health plans. The new operating model will be supported by guidance, including the strategic commissioning framework, which makes it clear that effective strategic commissioning depends on partnership between health and local authorities.
In addition, national oversight of ICBs will continue to consider the effectiveness of their partnership working, including through feedback from partners, which I think will give considerable opportunity to meet the concerns noble Lords are expressing. The noble Lord, Lord Kamall, asked, if these amendments are not necessary, which is what I am saying, how will ICBs draw on experiences and share good practice? We are able to provide ICBs with guidance, including best practice, and we will continue to do that, including examples of what has worked well.
Turning to Amendment 94 in the name of the noble Baroness, Lady Bennett, ICBs already have existing duties, including a duty to promote the integration of health and social care services. They already have the duty to co-operate with local authorities, and their triple-aim duty requires them to consider the wider effects of their decisions on health and wellbeing, the quality of services, and the sustainable and efficient use of resources. It includes consideration of the effect of decisions on health inequalities, and they will be held to account by the Secretary of State in working in this way.
I agree that collaboration—a word used by the noble Lord, Lord Redwood—between organisations is fundamental. I hope I can provide, and have provided, reassurance that this is already embedded in ICBs’ ways of working; so the additional requirement is unnecessary because it risks reducing the flexibility ICBs need to design services around local needs.
Before the noble Baroness sits down, I heard her talk about duties to deliver reductions in inequality. What my amendment is getting at, and which I did not hear from the noble Baroness, is the sense that the ICB is expected essentially to co-create: not just to tell these organisations what to do, but to get together with them to co-create. It might be useful, if the noble Baroness thinks that should happen, if she said so from the Dispatch Box.
I might use a slightly different word, but I think they mean similar things, if not the same thing. Throughout the Renewed Women’s Health Strategy is the need for co-production, and that has been absolutely important. The strategic commissioning framework also makes it clear that being effective in commissioning depends on the partnership with primary care and local authority providers, as well as the VCSE sector. Throughout, ICBs are required to work with their local communities in order to serve them.
My Lords, it has been a very interesting debate. Regarding women’s centres, I am very grateful to my noble friends Lady Royall of Blaisdon and Lord Bradley, the noble Lord, Lord Patel, and the noble Baroness, Lady Finlay. Taken as a whole, their speeches described the fantastic work women’s centres do, and such work is very much cross-service and cross-sector: the criminal justice system, homelessness, the health service and many other issues. My noble friend talked about the Renewed Women’s Health Strategy and the women’s voice partnership, and that is very welcome. The question is, given that the outcomes of having effective women’s centres are so powerful, why is provision so patchy? What is it about public services generally that gives them this short-term funding? Are we going to see much more, and more consistent, provision across the country, and can we set these centres up on a sustainable footing? The noble Baroness, Lady Finlay, made the business case for that very clearly.
On the amendments from the noble Baroness, Lady Bennett of Manor Castle, and the whole issue of integration, I say to the noble Lord, Lord Redwood, that the reason why integration is so important is that most of us have experience of relatives or friends—or ourselves—falling between the net of so many of these different statutory agencies at local level. I agree with him that there is an issue about accountability, though.
My Lords, I really do not have very much to add to the eloquent introduction to his amendment by the noble Lord, Lord Foster of Bath, except my own experience in this area.
Earlier in the year, I was contacted by a campaign group representing female prisoners that was complaining about the unequal access that they had to healthcare, particularly around cancer. I will repeat the Written Questions that I asked and touch upon the Answer that the Government gave at the time, and ask whether noble Lords and the Minister believe that that reflects reality rather than perception.
The first question I asked the Government was,
“what action they are taking to ensure that women in prison with cancer … are treated by appropriately qualified clinicians, and … have consistent access to oncology specialists”.
I then asked,
“what action they are taking to address any failures in cancer care arising from fragmented commissioning arrangements between NHS England, health and wellbeing boards and prison healthcare providers”.
I also asked the Government,
“what steps they are taking to prevent disruption of cancer treatment for patients following imprisonment”.
The last Question was,
“what assessment they have made of whether women diagnosed with cancer in prisons in England receive healthcare equivalent in quality, timeliness and continuity as that provided in the community”.
The Written Answer given by the Government at the time was that:
“NHS England commissions all services across the prison estate”,
and expects them
“to be equivalent with those … in the community, including for cancer care. All people received into prison have an initial health screen on arrival”,
and it then talked about risks. The Answer goes on to talk about a report from Chris Whitty called The Health of People in Prison, on Probation and in the Secure NHS Estate in England, published in November 2025. I was sent a copy of that report. When I sent the campaign group those Answers, it was very angry—so angry that it did not suggest any follow-up questions, as it felt it was a waste of time.
Given what the noble Lord, Lord Foster, has said today about the concerns around equity in treatment for those in prison—both those continuing treatment in prison and those starting treatment in prison and then having the same treatment outside prison—can the Minister address those points and the concerns raised by noble Lords across this Chamber from all Benches? Does she feel that, in reality, and given the Written Answers, that those people are getting the quality of care that they deserve, like anyone in the community?
My Lords, I am most grateful to the noble Lord, Lord Foster, and my noble friends Lord Bradley and Lady Royall, as well as the noble Baronesses, Lady Watkins and Lady Finlay, for speaking to this amendment. I have spoken previously about people with disadvantages when it comes to dealing with health needs and I certainly recognise that the group of which we speak continues to suffer disadvantage. That is one of the reasons why the Chief Medical Officer’s report is so key, and I was very pleased to discuss it with him.
To respond in part to the noble Lord, Lord Kamall, if groups or individuals that noble Lords are working with are unhappy about responses, they should by all means let me know precisely what it is that they seek and I will do my best to assist.
Earlier this year, through NHS England, we launched a pilot scheme—probation health pilots—across four areas, placing NHS clinicians directly into probation appointments to provide physical, mental health and addiction support for roughly 4,000 offenders. We are updating the NHS England national health and justice service specifications and reviewing prison reception screening processes to better catch health needs upon arrival and improve out-of-hours care. The Department of Health and Social Care and HM Prison and Probation Service are working on a multi-year response to the CMO’s report. These are all works in progress, which I hope will be helpful. I am glad that the noble Baroness, Lady Watkins, made particular reference to women in this regard, because it follows on from our debate on a previous group.
To speak briefly to the point of this amendment, providing appropriate care for people in custody is core to health and justice commissioning. To address the points raised by noble Lords, and indeed the amendment, ICBs will be required to meet all the reasonable needs of people who are in detention once the Bill transfers commissioning responsibility to them. The intention in transferring this responsibility is to support the joined-up care across the patient pathway that I think we all seek, which we know is not in place across the board, to improve access and outcomes, reduce inequality and strengthen the collaboration with local authorities. It is local authorities—the noble Baroness, Lady Finlay, raised this point—that commission social care for those in detention, and community drug and alcohol treatment, and other aspects of public health.
ICBs will have responsibilities for most of the health commissioning pathway from prisons and, to pick up the point about movement, to and from the community. I completely accept that health needs are no respecters of geographical boundaries or prison gates, as was referred to. Responsibility for the health commissioning pathway would ensure that commissioners are enabled to better do a joined-up job than is currently the case. On the point about moving ICB areas, we cannot expect people to stay neatly in areas. There will be national rules in place to identify which ICB has responsibility for care, and the single patient record will be greatly helpful in ensuring that health information follows the person.
The last point that I will make is about specialist services such as RECONNECT. We expect ICBs, as strategic commissioners, to champion services such as RECONNECT, because they provide much-needed pathway support on a whole range of issues that reduce health inequalities. National services specs and standards have been developed with the input of clinical and lived experience involvement. As part of the assurance framework with model regions, we expect ICBs to meet these specifications and standards as a minimum, and for the model regions to assure against it.
My Lords, I am grateful to all noble Lords who have spoken. I am grateful to the supporter of the amendment, the noble Lord, Lord Bradley, and to the noble Lord, Lord Kamall. I am particularly grateful for the support of the noble Baroness, Lady Finlay, with all her long expertise and work in this area. I am grateful, too, to the noble Baronesses, Lady Watkins and Lady Royall, for raising the issue of women in prison, where, undoubtedly, even more needs to be done than perhaps in the male estate—they are absolutely right to pick that up. I am particularly grateful to the noble Baroness, Lady Royall, for reminding us very clearly that people who go into prison are far more like to have mental health problems—whether drug, alcohol or gambling problems, or whatever they might be—than is the case in the regular population.
My Lords, I am grateful for this debate and for the group of amendments relating to neighbourhood health, not least because it is the core purpose of our shift from hospital to community and deserves consideration.
On Amendment 102, tabled by the noble Baroness, Lady Pidgeon, the retention of a requirement for health and well-being boards to publish both a joint local health and well-being strategy and a neighbourhood health plan could well cause unnecessary duplication. The reality is that neighbourhood health plans will be prepared jointly by the responsible local authority and its partner integrated care boards through the health and well-being board, and have to be informed by an assessment of local population needs. It is important that we avoid that risk of confusion. I take the point about things working well and the examples she gave, but we are trying to build on the strength of that to make sure we see things in better shape across the country. The noble Earl, Lord Howe, also asked about this whole area, so I hope he will take those comments as answers to his points too.
On some of the other points raised by the noble Baroness, I reiterate that neighbourhood health plans are intended to cover those core matters that are currently addressed through the joint local health and well-being strategies. That includes improving health and well-being, reducing health inequalities, supporting prevention and addressing the wider determinants of health, a point rightly spoken to by the noble Baroness, Lady Gerada. Neighbourhood health plans will continue to set out how local government, integrated care boards and their partners will work to improve the health and well-being of their population, drawing on public health, social care and wider local priorities, which is what noble Lords are rightly seeking. I will come back to the point raised about co-production.
In developing their plans, health and well-being boards have to involve the people who live or work in the area. The Government will support implementation through guidance developed with local systems.
On Amendment 101, tabled by the noble Baroness, Lady Barker, the neighbourhood health and strategic commissioning frameworks are clear. ICBs and local authorities should develop neighbourhood health plans with wider partners, as I have said, including, importantly, the voluntary, community and social enterprise sector. Statutory guidance on joint strategic needs assessments, which must underpin those plans, also emphasises voluntary sector partnership working. If I understood the question the noble Baroness asked, which was straightforward, I will answer straightforwardly and confirm that ICBs are responsible for commissioning primary care services for their local areas—it sits firmly there.
On Amendment 100A, tabled by the noble Baroness, Lady Finlay, who raised the point about co-production, I can reassure her that the neighbourhood health framework sets an expectation that ICBs will work with clinicians, such as allied health professionals, which we heard about in an earlier group, to develop those plans, and recognises the importance of prevention and rehabilitation. Existing statutory duties concerning the prevention and delay of care needs and support for people with care needs will also continue to apply.
On Amendments 96 and 98, tabled by the noble Baroness, Lady Tyler, supporting people with care needs and unpaid carers—the groups to which she referred—is a priority of this Government. The existing Care Act 2014 has duties that require local authorities to promote the well-being of people with care needs and carers, and integration of care and support with health services. I assure the noble Baroness that we expect local partners to consider the needs of unpaid carers where these have been identified through the joint strategic needs assessment, alongside other locally identified needs.
I agree with the principle raised in Amendment 95 by the noble Baroness, Lady Tyler. The plans will inform the decisions of the responsible local authority and its partner integrated care board or boards, but they should not prescribe individual commissioning decisions. We do not believe that the level of detail being sought belongs in primary legislation.
The noble Baroness also asked about practical deliverability in respect of workforce and service capacity. They are important considerations, of course, if we are to deliver effective neighbourhood health services. As noble Lords will be aware, our approach is to ensure flexibility for local areas to determine how they plan their workforce and capacity. In March, we published a neighbourhood health framework to empower local leaders to develop and scale the neighbourhood health services that they need. The framework outlines the national minimum goals—that goes to some of the points raised by the noble Baroness, Lady Manzoor—and the objectives of neighbourhood health.
I turn to Amendment 97, tabled by the noble Baroness, Lady Scott, and Amendment 99, tabled by the noble Lord, Lord Londesborough. I am grateful to the noble Baroness for speaking to her experience of ME, and to the noble Lord for raising neurological conditions. I recall very well his Question in the Chamber, which I was pleased to answer, on migraine, which I know he has much personal experience of.
To reiterate, neighbourhood health plans need to be informed by the needs of all the people who live in an area. I know that noble Lords have heard me say this before, but it is our view that prescribing individual conditions or cohorts in primary legislation, which is proposed in the amendment, would reduce the flexibility of local partners to respond to their populations’ particular needs and priorities. It is not a point of ignoring the issues that the noble Lord and the noble Baroness raise; it is about preserving the flexibility to meet the needs properly in the way that they describe.
Our neighbourhood health framework builds on existing duties and frameworks that encompass those people who have long-term, complex or fluctuating health conditions, which is a great number of people indeed. The neighbourhood health framework supports ICBs and local authorities to develop locally led neighbourhood health plans.
On the issue of accountability, the arrangements that I have outlined do not replace existing accountability for delivery. A number of noble Lords spoke about accountability. To reiterate, it is the case that ICBs are accountable for the NHS services that they commission, and local authorities remain accountable for the services for which they are responsible. Health and well-being boards provide the collective leadership for local neighbourhood health plans, bringing partners together around shared outcomes. National minimum goals and measures, as I mentioned earlier, provide a consistent basis for tracking progress across the country. I very much hear what noble Lords are saying about how we know, how it is delivered, and how accountability is applied.
My Lords, I will speak first to Amendment 104ZA tabled by the noble Lord, Lord Scriven, to which I added my name. The noble Lord, as he so often does, has put his finger on the button. Throughout our consideration of the Bill, we have repeatedly questioned the Government about the practical implications of abolishing NHS England, the costs of the reorganisation and precisely how the new arrangements will operate. We have asked how responsibilities would be transferred, where accountability would ultimately lie and how the Government could be confident that this substantial reorganisation would deliver the efficiencies and improvements in patient care that Ministers have promised—and here we are again. We now learn that, alongside the abolition of NHS England and the transfer of its functions into the department, the Government intend to establish a new special health authority in which to house the seven regional NHS teams, totalling about 3,000 people.
The Government have said that the main justification for abolishing NHS England is to reduce duplication, streamline administration, improve accountability and deliver substantial savings. Yet, like it or not, as with any new public body, this new special health authority will have its own governance arrangements, administrative staffing requirements, operating costs and lines of accountability. As was well said by the noble Lord, Lord Scriven, we are in the dark on so much of that, if not all of it. From the outside, it looks remarkably as though we are just transferring substantial parts of NHS England’s organisational infrastructure into another arm’s-length body. The Secretary of State has described this as a “temporary arrangement” intended to
“support the transition to a more devolved model”,
but we need to ask—as the noble Lord, Lord Scriven, did—what “temporary” means in this context. If it is temporary, what needs to happen before the way is clear for the SHA to be abolished and its functions transferred elsewhere?
As we all know, the creation of this SHA has been born of necessity because of the differing pay structures in the NHS and the Civil Service, so the obvious question is: when in the future is that situation likely to change? The explanation offered by the Secretary of State that she wishes to keep the NHS regional teams closer to the front-line services sounds very much like post hoc rationalising. The regional teams were surely never going to move physically to an office in central London.
That brings me back to the question of cost, which is central to my noble friend Lord Blencathra’s Amendment 279QB. We have already seen estimates suggesting that the redundancy costs associated with abolishing NHS England could reach between £1 billion and £1.3 billion. Those are substantial sums of public money, and it is only reasonable that Parliament should be satisfied that they will result in genuine, lasting savings.
My noble friend Lord Blencathra is unable to be present this evening, but I understand entirely the concern underlying his amendment, which is that we must not find ourselves paying substantial redundancy packages to staff who subsequently return to the NHS in different roles, potentially at considerable additional expense to the taxpayer. I note the comments of the noble Lord, Lord Hunt of Kings Heath, that this is unlikely to happen, but I have personally seen it happen in the past. Surely the minimum we are entitled to expect from the abolition of NHS England is genuine efficiencies. I am sure that the Government wish to achieve that. Can the Minister assure me that the job cuts that are to apply across NHS England will not be imposed in a way that brings headline numbers down but then requires the same expertise to be brought in by the side door under a different cost heading?
Moving back to the amendment from the noble Lord, Lord Scriven, I hope that the Minister can provide some further clarity about the proposed SHA, its funding, its intended lifespan and the arrangements for transferring its functions into the Government’s longer-term model. Ultimately, the test of this reorganisation is not whether the Government can claim to have abolished NHS England but whether the new system will be simpler, more accountable, less expensive and, most importantly, better for patients. I look forward to the Minister’s response.
My Lords, I appreciate the debate we have just had and the questions that have been put. I will answer some of the headline questions but I will write answers to others, in view of the time. Overall, I reassure the noble Lord, Lord Scriven, and express my appreciation for my noble friend Lord Hunt’s support. The noble Lord, Lord Stevens, used the word pragmatic about establishing a special health authority; it is rather important that we come back to that, because that is exactly what we are doing. Parliament has already provided a very clear process for establishing special health authorities under Section 28 of the National Health Service Act 2006, so it is not an unusual or random thing, or something that we have just come up with; it dates back to then.
To answer some of the questions in broad terms about establishing the special health authorities: we will follow the process set out in that legislation. We will set out the authority’s general functions, governance arrangements and appointments in the establishment order and regulations, which, as statutory instruments, will be subject to scrutiny by both Houses of Parliament in the usual way.
The noble Earl, Lord Howe, raised a question—I hesitate to put words into his mouth, but I will summarise it as I heard it—about whether this is just NHS England being reincarnated in some way. No, it is not. NHS England is a national organisation. It has wide-ranging statutory and operational responsibilities. A special health authority would very much be a smaller body with a narrow, regional remit. It would not be a new national HQ for the NHS; there is no national policy or operational role, and we will not allocate resources across the National Health Service. Those responsibilities would be with the department, with ICBs or with other appropriate organisations.
The authority will be directly accountable to the Secretary of State, so there will be clear democratic oversight. Where a direction is necessary, we expect the special health authority to work closely with Ministers to determine what action is needed. The Government very much recognise the importance of financial oversight throughout this transition, including costs, savings and value for money. Costs will be set out through the usual financial reporting processes. We do not expect the organisational home of the regions to materially affect their overall size or cost.
On some of the points that the noble Lord, Lord Scriven, raised, we have signalled that this should be a temporary arrangement—and I shall use another word that the noble Lord referred to—that will support the transition to a more devolved model, reflecting the fact that regional arrangements that we are putting in place for 1 April next year may evolve depending on how the NHS develops, including the ways they support local areas as devolution continues. The devolution agenda is still emerging, so we do not wish to set an arbitrary countdown for any subsequent reform. It is not an omission; it is just a reality that we find ourselves with.
The additional statutory requirements in Amendment 104ZA would overlap with existing requirements. We believe they would add process and risk delay, and we therefore consider it unnecessary. I absolutely recognise Parliament’s legitimate interest in this process, and we will keep Parliament appropriately informed. Noble Lords will be pleased for me to remind them that tomorrow there is an information session where they will have the opportunity to discuss the details of this. That is one way in which we will do this.
I will refer only briefly to Amendment 279QB tabled by the noble Lord, Lord Blencathra, on the basis that nobody spoke to it—I think that is correct. Safeguards are in place. We have voluntary redundancy programmes implemented within NHS England, commissioning support units and integrated care boards. They all include contractual exit arrangements that require all employees who leave under voluntary redundancy and then obtain employment with another NHS employer up to 12 months afterwards to repay some or all of their redundancy payments. My noble friend Lord Hunt made a very direct assessment of the amendment. I can more politely say that we think the requirements in the amendment are disproportionate and would be unnecessary in that they would restrict NHS organisations from recruiting experienced staff where their skills are needed, so it would go significantly further without adding anything.
My Lords, because of the hour, I will be very brief. I thank all noble Lords who have spoken in the debate. We have prodded, poked and tried to get answers. I appreciate that the Minister has given us an overview. To use the Tears for Fears song “Woman in Chains”, I feel that the chains of responsibility are there. To use another Tears for Fears song, we asked her to “Break it Down Again”, but at this moment she is not able to break down exactly what will happen.
I understand that it is pragmatic and there may be issues that the Government will use in the special authority, but the key is that there are five months before 1 April when all this has to be in place. As the noble Baroness, Lady Thornton, said on a previous amendment, this is a Bill of moving parts. It has now become a Bill of new parts with great uncertainty. I am sure we will want to return to this before Report, and I hope the Minister can answer some of those questions in more detail. With that said, I beg leave to withdraw the amendment.
(1 day, 23 hours ago)
Lords ChamberMy Lords, I am most grateful to all noble Lords for laying these amendments and speaking to them, because this is an important topic. I want to confirm that I have heard the points being made, which have gone across a wide range of issues to do with children and young people. I will endeavour to focus on the amendments, as I know noble Lords will understand.
Turning first to Amendment 66, tabled in the name of the noble Baroness, Lady Cass, I can give her the assurance that the duties in the Bill on the Secretary of State and ICBs apply to everybody. The Bill deliberately does not identify specific groups. I understand the reason for her suggesting it, but it specifically does not do that: first, to protect the universality of the National Health Service, but also to avoid more of what we might call cliff edges between different groups, something that I know is of major concern across our Chamber.
However, I absolutely agree with the noble Baroness and other noble Lords that national access and waiting time standards drive consistency, transparency and accountability. I draw your Lordships’ attention to new Clause 16, which already allows Ministers to set waiting times through regulations. Existing standards, including the 18-week referral to treatment and the cancer standards, already cover children and young people, and that will continue. NHS England now publishes monthly elective waiting list data, with demographic breakdowns, which comes out alongside information and targets on children’s and young people’s community service waits. We are also working to support, through NHS England, the most challenged NHS trusts, and I can give the assurance that that will continue after NHS England is abolished.
I will address the noble Baroness’s other amendments, Amendments 249 and 279QN. As the noble Baronesses, Lady Cass and Lady Tyler, and other noble Lords referred to, it is a commitment of this Government—a laudable one, I think we can all agree—to raise the healthiest generation of children ever. That is why we are in the process of developing a modern service framework for babies, children and young people, which will be an evidence-based and ambitious delivery plan for ICBs to make a real step change in response to the needs of this group. The noble Baroness, Lady Tyler, asked about specific timelines. I cannot give those today because the framework is in development but, of course, when I have information, I will be very pleased to update noble Lords.
We will also shortly be setting out our vision for mayoral strategic authorities, so that we can better align local services around the needs of their communities, including those of children and young people. The modern service framework will cover children and young people up to the age of 18. On a point that noble Lords have rightly raised on other occasions, it will also cover children and young people up to 25, which I know has been a matter of concern. That will be in respect of those with SEND, mental health and neurodevelopmental needs. Earlier this year, NHS England published guidance for those aged nought to 25 to support the transition, which we know has presented challenges, for a child or young person as they grow older and move through children’s services into adolescent and adult services.
On the point made by the noble Baroness, Lady Benjamin, speech and language support is being provided through Best Start Family Hubs, ELSEC and Experts at Hand. There is now national guidance that ICBs must commission speech and language therapy.
The noble Lord, Lord Russell, raised the matter of how we reduce health inequalities, which runs throughout the 10-year health plan. The national outcomes are set out clearly, are measurable and are core to the 10-year health plan, as I said. We have also strengthened national oversight of how we reduce health inequalities. On measuring performance, which was also a point raised by the noble Lord, Lord Russell, children’s health outcomes are already monitored and reported through the Fingertips platform and the local outcomes framework. It is therefore our view that new statutory targets would be duplicative and would risk diverting capacity away from delivering on the existing commitments.
We absolutely share the ambition behind Amendment 232, tabled by the noble Baroness, Lady Tyler. But it is important to set out that it is our view that the health outcomes for children are not driven by NHS investment alone. ICBs operate within a much wider system, with outcomes shaped by many wider determinants of health, as we have discussed on a number of occasions, including, for example, housing, to name just one. It is our view that, as the amendment requires ICBs to link specific investment directly to outcomes, that would risk giving a misleading picture of what is driving change and would not actually get us to the place that we seek to get to.
On Amendment 161, tabled by the right reverend Prelate the Bishop of Leicester and spoken to with immense understanding and support by a number of noble Lords—and I understand why—including my noble friend Lady Morgan, the noble Lords, Lord Russell and Lord Young, and the noble Baroness, Lady Tyler, I am in full agreement that adopted children deserve safe, continuous healthcare, as do all children regardless of circumstances. It matters that relevant health information follows them through adoption.
Specifically on the amendment, I hope the right reverend Prelate will appreciate that placing the duties in primary legislation would inadvertently—and I know that is the word—remove the flexibility to protect a child’s identity in certain circumstances where a new NHS number may still be necessary, for example to protect their safety, and I know all noble Lords will understand that. I can confirm that work is ongoing to understand the detailed policy, technical and safeguarding implications, and I am grateful to the noble Lord, Lord Young, for his common-sense suggestions as to various ways forward. I certainly commit to updating the Committee on progress in this regard, and I would be very pleased to meet the right reverend Prelate. We have to safeguard children in what can be very challenging circumstances.
On Amendment 243, tabled by the noble Baroness, Lady Finlay, I share the view that decisions about the care of a critically ill child can be distressing as well as urgent, as the noble Baroness referred to. It is crucial that families and medical professionals communicate, and, where possible, that they reach agreement on what is in the child’s best interests. To this point, the Royal College of Paediatrics and Child Health is updating its framework for clinical practice on navigating decisions to provide, limit or withdraw treatment. There is also an NHS e-learning platform to support staff in communicating with and involving families in decision-making and de-escalating disagreement. These resources are already helping to embed best practices on shared decision-making and communication with parents across the system.
Finally, I will address the amendments tabled by the noble Baronesses, Lady Penn, Lady Cass and Lady Barran. On Amendment 279P, tabled by the noble Baroness, Lady Barran, I assure her that the safety of digital health technologies is taken seriously. Local NHS bodies are already required to assess digital health technologies against the digital and technology assessment criteria before purchasing them. This assesses compliance with various national standards, including for clinical safety, privacy and data protection, cyber security, interoperability, usability and accessibility.
On the point raised about AI chatbots, both by the noble Baroness, Lady Barran, and the noble Baroness, Lady Benjamin, yes, people are indeed using them, as we know, for mental health advice. The noble Baroness gave one example. My point would be that these must not replace trained professionals. The reality is that they can be unsafe and can give unsuitable advice. However, we do see a role for AI chatbots and their potential for safe use in routine work—for example, in making appointments, taking notes and answering basic inquiries—and any AI that is introduced into NHS services must comply with standards for safety, effectiveness, ethics and data protection. More broadly, clinical observations can provide valuable early warning signals.
To the noble Baroness, Lady Penn, I say that, yes, we do recognise the physical and mental health impacts of screen time and content, and that is why we are taking a number of the actions that noble Lords have referred to. However, the amendments that propose statutory reporting systems spanning digital devices, services and content would require clear criteria and careful co-ordination with existing regulatory arrangements. On those, we feel that the priority should be to strengthen existing routes for surveillance, evidence gathering and regulatory action, rather than starting afresh. That said, I take the points that have been made.
I turn to Amendment 98A—
I hope the Minister will forgive me if she is about to address this. In relation to my Amendment 279P, she went through a list of standards—forgive me, I did not capture the name of the specific standards—that included data protection, cyber et cetera. The point I was trying to capture in my amendment was the latent risk in a child having a smartphone, which allows them to do a number of other things, including accessing entirely age-inappropriate and unsafe material. I will understand if the Minister needs to reflect on that, but perhaps she could write to me if that is the case.
I am happy to come on to broader points. I particularly want to address the noble Baroness’s amendments in respect of health technology, which made her amendments different from the others in the group.
On Amendment 98A, in the name of the noble Baroness, Lady Penn, through local neighbourhood health plans, local partners are already expected to reflect the needs of the whole population, including children. If necessary, we can look at whether we need to provide guidance to reinforce that message. I emphasise to all noble Lords, who have made salient points, that digital harms can be considered alongside other factors affecting children’s health, with plans setting out how identified needs will be met.
To address the underlying concerns of Amendments 279F and 279G, we are already taking action to support key professionals working with children and families, providing them with tailored guidance and training. I say to all noble Lords, especially the noble Baroness, Lady Penn, that the healthy child programme is central to all this. It reinforces the need for healthy routines for screen use, alongside all the other measures that we are taking across government. I am grateful to the noble Baroness, Lady Kidron, for her reflections on the broad environment in which children and young people are operating.
Following this debate, which has revealed that children are not just little adults, would the Minister consider a government amendment to the Bill to ensure that all the duties of the Secretary of State are appropriately focused on the age and developmental stage of each person as an overarching policy in health? That would then be compatible and link with the healthy child programme overall in other areas.
I agree that children are not little adults; I am not sure I can say that adults are not sometimes larger children. I understand the point that the noble Baroness makes. However, the Secretary of State’s powers and the Bill do not identify specific groups for the reasons that I set out at the beginning. I refer the noble Baroness to those, although I understand the intent behind her point.
I recognise the acknowledgement of my broader points, but we are absolutely desperate for evidence to give to Ofcom so that its regime works. Would the Minister be willing, before Report, to talk about creating a way for clinicians to record their concerns, so that they can be taken seriously by Ofcom and to close the loop?
I understand the point the noble Baroness makes. I cannot commit to being extremely detailed before Report, but I can commit to taking on board the point she raises.
On my amendments, I appreciate that children’s digital environment can be addressed in the existing frameworks, but my question is whether it is indeed being addressed through existing frameworks. The Minister referred to guidance and training, and I would be grateful to hear more detail on that before Report, either through writing or engagement.
On the child health programme, which the Minister acknowledged was crucial, as I said in my speech, there is a reference in those two reviews to screen time and healthy routines, but that was it, as far as I could find. My question relates to that guidance and training: what confidence do we have that these things are being addressed, not just that they could or can be addressed by those health professionals?
I understand what the noble Baroness is saying. I would be very pleased to write to her.
Baroness Cass (CB)
I thank the Minister for taking us through the measures that the Government are taking in the areas that we have just discussed, in particular in terms of monitoring things such as waiting lists. I appreciate that there is all-age monitoring; that is a significant theme of the Minister’s comments in not separating children and young people from adults in the Bill. However, the reason why we have brought this group of amendments—which range from system level through our very broad concerns about the digital environment to some specific things, such as NHS numbers and children close to death—is because it represents a package of concerns about things that we feel are not working. You might almost think that we have colluded across the Chamber to pull this together.
Although we appreciate that much is going on, none the less, it is not reassuring for us to feel that things are being monitored unless there is a plan for taking action. It remains the case that children’s outcomes and processes, such as waiting times, are falling behind those of adults and of children in other European countries. Adolescents, in particular, are different from others within the NHS in that they fall between the cracks of the children’s and adult services. We cannot afford to wait too long to do something about that significant gap. For all the reasons that we have said, the digital issues require us to be as proactive as possible.
I am sure that some of us will be beating a track to the Minister’s door between now and Report on some of these issues. I thank colleagues across the Committee for their contributions. With that, I beg leave to withdraw my amendment.
My Lords, I am most grateful to all noble Lords who have tabled amendments and spoken in this debate. Turning first to Amendment 91, in the name of my noble friend Lady Royall, the Government’s commitment to halve violence against women and girls within a decade includes tackling stalking. I take the point that my noble friend made that not all stalking is specifically in that area. Nevertheless, this is a strong government commitment to be applauded.
The Crime and Policing Act 2026 will require the Home Secretary to issue multi-agency statutory guidance on identifying stalking, supporting victims and tackling perpetrators, and healthcare authorities must have regard to it. Furthermore, the Victims and Prisoners Act 2024 requires integrated care boards, alongside police and crime commissioners and upper-tier local authorities, to collaborate on commissioning support for victims of domestic abuse, sexual abuse and serious violence; it also requires them to publish a joint strategy.
I say to the noble Lords, Lord Russell and Lord Evans, that I am sure the Home Office is aware of the very good practice in Cheshire. I will of course ensure that that is known to it, but I expect that the Home Office is aware.
The point that the noble Baroness, Lady Royall, and I were trying to make is that is fine for the Home Office to be aware of this and to be co-ordinating. What the harm reduction unit in Cheshire is hoping would be the case is that the Department of Health itself would take partial ownership of this and mandate it as best practice, and that as a matter of policy and practice, the NHS should be much more directly involved in this area, rather than waiting for the Home Office to perhaps include it in a strategy, which means that nothing may happen.
I may have inadvertently given the noble Lord the wrong impression, but to restate: we are required to publish a joint strategy. The important thing about this year’s Crime and Policing Act is also that multi-agency statutory approach. Looking at good practice, as the noble Lord has said, is absolutely part of that.
We also expect ICBs to commission specialist stalking services to meet the needs of their populations. This amendment would create a bespoke statutory health duty separate from the Home Secretary’s multi-agency framework, which I fear would risk duplication. I know that it would do so inadvertently but it could also create confusion in what is, as we are all agreed, a critical area.
That brings me to Amendment 70 in the name of the noble Baroness, Lady Barker. The voluntary, community and social enterprise sector plays an absolutely vital role in health and social care, as we have discussed previously, but the Government do not feel that the amendment is the right route to promote its involvement.
The provider selection regime already allows ICBs to weight social value and to directly award contracts to well-performing voluntary providers. The Bill also empowers ICBs to financially or otherwise support organisations whose activities benefit the health service. These routes support VCSE organisations according to local need, without guaranteeing work that others may be better placed to undertake. The concern about this amendment is that it would set a harmful precedent of choosing providers by type rather than their ability to provide—something which would go against the Bill’s commitment to neutrality with respect to providers, as we discussed at some length in relation to Clause 10.
I turn to Amendment 163, which was also tabled by the noble Baroness, Lady Barker; the noble Baroness, Lady Bennett, also spoke to it. The noble Baronesses are right that confidentiality is essential in all healthcare settings, particularly in sexual health services. Clause 52 allows us to use regulations to set out which information can or must be made available and who can access it. Our intention is that access should be limited to the information that people need for their role in providing care, and that professionals accessing the record to provide direct care must remain subject to their duties of confidentiality. The anticipated detailed arrangements for sexual health information will need to address patients’ expectations of confidentiality.
There are already important protections in law and guidance. Sections 251A and 251B of the Health and Social Care Act 2012 contain exceptions to the duties concerning the NHS number and information-sharing where information concerns, or is connected with, services provided by an anonymous access provider. Information about a person’s health or sex life is also protected as a special category of data.
I turn to Clauses 42 and 43, which were spoken to by the noble Baroness, Lady Coffey. I will endeavour to assist if there are areas about which the noble Baroness is still unclear; I would be very happy to pick that up further with her. Clause 42 is a technical change. It brings the statute book on a specific area of commissioning in line with broader commissioning arrangements across primary care. It will not affect patients in rural areas who are eligible to receive medicines from dispensing doctors; they will continue to receive the same service.
Clause 43 ensures that ICBs can respond swiftly when exceptional circumstances disrupt access to pharmaceutical services, while maintaining safeguards and national oversight. Section 133 of the NHS Act 2006 would already apply to a disruption affecting the provision of services by dispensing doctors as well as NHS pharmacies. Clause 43 therefore clarifies that ICBs may act in exceptional circumstances regardless of scale. It removes unnecessary provision which would require the Secretary of State themselves to make arrangements, and it clarifies that authorisation to ICBs should be given through directions.
Baroness Royall of Blaisdon (Lab)
Can I ask my noble friend the Minister for confirmation on one point? When the Secretary of State announced an investment of £50 million to combat the disease of domestic violence, I have no doubt that what she would have wanted to say is that this could be used to combat domestic violence and stalking. I would be grateful if that confirmation could be made.
I will be very pleased to write to my noble friend with more details.
My Lords, I thank all noble Lords who took part in this debate. It was a good thing to highlight the importance of the role of the voluntary sector, which often gets overlooked, not least because it tends to deliver additional services to that which are in a basic NHS-commissioned brief, and that sometimes gets lost. I ask the Minister to clarify this: am I right in understanding from what she said that Section 251 of the Health and Social Care Act 2012 will remain in force? Will it therefore still be the case that whatever detail is set out in regulation, there is still a right for people to access services anonymously?
I believe I referred to that, but I will check what I have said on the record. Again, I will write to the noble Baroness to be quite clear.
I would be thankful if she could do that, because I stand by the point that that principle remains an important part of providing comprehensive health services, in particular public health services. With that, I beg leave to withdraw my amendment.
(1 week ago)
Lords ChamberThat the draft Regulations laid before the House on 14 September be approved.
Relevant document:13th Report from the Secondary Legislation Scrutiny Committee. Considered in Grand Committee on 10 November.
(1 week ago)
Lords ChamberMy Lords, I am most grateful to noble Lords for their contributions to this debate. As before, I will focus on the amendments before us. I start with the future of the NHS federated data platform and the noble Lord, Lord Clement-Jones, who spoke to his Amendments 158, 159 and 172E, and the noble Baroness, Lady Bennett, who spoke to her Amendment 172B.
As I hope noble Lords will agree, decisions about public contracts must be made through fair, open and non-discriminatory processes, which is the point the noble Lord, Lord Kamall, was making. This is governed by UK procurement law and it ensures we get the best outcomes and solutions for the National Health Service. NHS England is reviewing the contract to determine whether it should continue, subject to standard contract management processes and government approvals. This process remains ongoing and decisions will be announced formally.
I can assure your Lordships’ House that the FDP operates under the direction of the NHS and each trust and ICB that has signed up uses it as it sees fit. Furthermore, Article 25 of the UK GDPR, which requires organisations to include data protection by design and default, already applies to the FDP. Were data to be anonymised as Amendment 158 proposes, it would prevent the delivery of national services such as national vaccination and screening, and key activity supporting the management, operation and provision of national health services.
I feel it would be helpful to set out the potential implications of Amendment 172B. When it was tabled, the usual channels received advice from the House authorities that the amendment would, in their view, risk making the Bill hybrid as it seeks to put in the Bill that the contract of one specific company is not extended. If the Bill is hybridised through amendment, those affected will have the opportunity to petition, after which the Bill will be referred to a Select Committee.
Can the Minister confirm the date when the decision will be announced on whether or not there will be retendering of that FDP Foundry contract?
I am not able to confirm the exact date, but I can say, as I said earlier, that the decision will be announced formally, so noble Lords will be made aware.
On the questions of security, resilience and sovereign capability, as raised in Amendments 53, 171 and 289 by the noble Lord, Lord Tarassenko, the Government share his determination to protect patient data and to support the strong UK digital health market. However, I am not able to commit to an NHS digital sovereignty strategy, nor additional legislation. Supply risk is not determined by nationality or jurisdiction alone. What matters is the data involved, who can access it, the supplies controls and the contractual protections in place. We already have robust safeguards. The Procurement Act 2023, about which much has been spoken, provides powers to exclude suppliers where appropriate, including on national security grounds. It also provides for setting data protection and cyber security requirements.
I note specifically the noble Lord’s concerns about the procurement of the single patient record, and I am looking forward to a more focused discussion, as I know all noble Lords are, on the SPR at a later Committee stage. I can confirm now that the procurement will have to ensure the resilience of our systems, how we keep within the UK jurisdiction and that the data remains under NHS control. The noble Lord, Lord Tarassenko, raised concerns that foreign laws could require an overseas supplier to give access to NHS data. We take that risk extremely seriously and aim to ensure that the legal, contractual and cyber-security safeguards are in place to avoid this.
I fully endorse encouraging domestic innovation, as I hope noble Lords are aware. As the Chancellor set out in the recent Budget, the Government will use public procurement strategically to back British firms to strengthen domestic capability and to build resilience in key supply chains. We will continue to promote international investment and trade and to open opportunities for British businesses at home and in markets around the world.
The noble Baroness, Lady Kidron, indicated her agreement with the noble Lord, Lord Tarassenko, in this area. The points on sovereign data being an asset will come back in the group beginning with Amendment 142, and again I look forward to debating that. We want a vibrant UK market for tech, and practical action is already under way. NHS England is engaging industry ahead of procurements, structuring opportunities to increase SME participation, and using social value to support good jobs and skills, which we all want to see.
I turn to Amendment 279A, tabled by the noble Lord, Lord Austin. He too raises the important question of accountability within this amendment, and we agree that contracting authorities should be accountable to the objectives of the Procurement Act, which already apply directly to covered procurement. The Act also provides transparency and oversight mechanisms, including powers to investigate compliance. The Procurement Act 2023 already requires publication of contract details for contracts worth over £5 million and, where applicable, key performance indicators and annual assessments of supplier performance against them. This makes a further NHS-specific annual reporting duty unnecessary in our view. For medtech, our value-based procurement approach further supports decisions focused on patient outcomes, total care costs, and longer-term value.
The amendment from the noble Lord, Lord Austin, refers to
“medical devices, consumables and services”.
There are two laws in place for procurement for the NHS: one for services and one for goods. What about the services? We have heard about the goods, but what about the accountability and feedback for services?
I made reference to the Procurement Act 2023, and that is the guide by which we go.
It is for goods, but NHS services come under the 2022 health Act. There was discussion about whether it should have all fallen under one procurement law, but for NHS goods it is the 2023 Act, and for services it is the 2022 health Act that is applicable. If the Minister could write to me and place a copy in the Library, it would be helpful to see how the health Act also applies.
So many health Acts. I would, of course, be very happy to do that.
I turn to Amendments 144, 147 and 160, tabled by the noble Lord, Lord Clement-Jones. I recognise the importance of ensuring that NHS IT and data procurements are fair and competitive, and protect the interests of patients and taxpayers. However, there is already extensive procurement law governing the department and NHS organisations. The Government agree with the objective of avoiding supplier lock-in. However, ownership of all connector IP is neither necessary nor the most effective means of achieving that. Appropriate licensing rights, interoperability requirements, open standards and exit provisions can protect portability and future competition without prescribing a single ownership model. Similarly, a blanket prohibition on suppliers that have previously provided free services could have unforeseen consequences, including for voluntary sector providers. Existing procurement rules provide safeguards against unfair incumbent advantage.
The Minister mentioned existing procurement rules, and she gave a partial nod to my Amendments 144, 147 and 160, but said it was not always desirable for all those elements to be observed. Perhaps she could write and say which bits of those amendments—which are quite technical, I admit, dealing with interoperability, data connectors and the prevention of supplier lock-in—she means. It would be helpful if she could write and explain how the procurement rules that she prays in aid achieve some of those objectives.
The Minister referred to national security grounds being considered in the letting of these contracts. When we talk about national security, traditionally we have thought about hostile states proving a threat, but now we are in the context of the broligarchy—tech oligarchs who wield enormous power and influence, frequently opaquely held, with links to far-right politics and Governments who are funding far-right forces in the UK and around Europe. Is the Minister confident that that kind of national security threat is adequately considered when we look at contracts?
That is not a matter I feel able to reply to in detail right now, although I will gladly write. However, to the best of my knowledge, the interpretation of what represents a threat to national security is set out and is understood.
Lord Tarassenko (CB)
I thank all noble Lords who have spoken. I think we have mostly sung from the same hymn sheet, with perhaps the odd discordant note—maybe even a few bars, maybe even a whole movement, some people might argue. I am grateful to the Minister for her comprehensive reply.
I found it heartening last week to hear the Secretary of State speak positively about sovereign data and sovereign AI—those were her words. We now have an opportunity to go from concept to implementation within the next two years—namely, the single patient record contracts; that is, not the FDP contracts but the new contracts for the single patient record.
I believe, and I believe that many other noble Lords agree with me, that we have a highly capable—world-leading, I would say—UK medical technology and software sector, with companies that are often university spin-outs now ready to scale up. None of my amendments is in contradiction with the Procurement Act. I believe these companies can win these SPR contracts on merit. We are talking about supporting UK excellence, but we need to remember that the US spends billions to support technology in a radically different, profit-driven healthcare system, which often produces software that has a very poor fit to the NHS. I am sure the noble Lord, Lord Lansley, will be able to tell us that the original EPRs, the electronic patient records, from companies such as Epic and Cerner were a poor fit because they were designed for billing purposes, not for optimising patient outcomes. We made that mistake with the EPRs; let us not make the same mistake with the SPR.
In general, because the UK businesses are much smaller than the Oracles, the Epics, the Palantirs and the IBMs, we need a level playing field. I suggest that we need a signal from the Government to those companies that the Government are keen for them, as was mentioned by the Minister, to use procurement strategically to back UK business. I think that signal is the NHS digital sovereignty strategy, and I believe we will come back to it on Report. I beg leave to withdraw my amendment.
My Lords, I start by welcoming Amendment 54, as tabled by my noble friend Lord Lansley. It raises an important concern about eligibility for NHS continuing care. Someone suffering from a serious chronic condition, including severe dementia, should not find themselves disadvantaged in comparison with someone with terminal cancer simply because their condition fluctuates or because they are not considered to be approaching the end of life. Eligibility should be determined by the intensity and complexity of a person’s needs rather than by arbitrary distinctions. Having said that, and while the concept of continuing care is one that we can all embrace, its quality and delivery, as the noble Baroness, Lady Barker, so succinctly reminded us, often fall far short of the ideal. Can the Minister therefore say whether the Government will consider making the existing eligibility framework more responsive to the patients that my noble friend described?
I also welcome my noble friend Lord Harlech’s Amendment 279QE. Recognising the particular medical and dental fitness requirements of reservists is a sensible and clearly proportionate measure. The amendment does not displace the key principle, as he explained, that clinical need must remain paramount in this context. Can the Minister explain how the Government currently expect health bodies to recognise the particular circumstances of reservists and whether further guidance might be necessary?
This debate has been characterised by a consistent measure of concern around commissioning. We have seen this through Amendments 57, 59 and 73, as tabled by the noble Baronesses, Lady Grey-Thompson and Lady Pidgeon, who are seeking greater transparency through impact assessments and reporting requirements, particularly where specialised services are transferred to ICBs.
The noble Lord, Lord Hunt of Kings Heath, in Amendment 58, similarly highlights allergy provision. All this argues for Amendment 80, as tabled by the noble Baroness, Lady Grey-Thompson, which seeks greater scrutiny of the performance of ICBs.
As a significant number of the amendments in this group highlight, including those from the noble Baroness, Lady Scott of Needham Market, and the noble Lord, Lord Sharkey, there is concern that the Secretary of State, with so many priorities, will be unable to provide acceptable standards for certain groups. Accountability and consistency of standards cannot just be taken as a given or as things that will come out magically in the wash. It would be helpful if the Minister could explain to the Committee how the Government intend to reconcile these objectives.
In particular, where specialised commissioning is transferred to ICBs, who will be responsible for ensuring that the necessary commissioning capacity and expertise will be in place? Amendment 74, from the noble Lord, Lord Sharkey, and my noble friends Lady Sater and Lady Chisholm, asks a corresponding and equally important question around clinical leadership. As the noble Lord, Lord Scriven, expressed so well, the amendments in this group demonstrate the complexity of the decisions involved in commissioning healthcare, particularly for specialised services. I do think that further and better particulars are required from the Government before any of us can feel comfortable with the direction in which we are heading.
My Lords, I am most grateful for this debate. I will endeavour to pick up most of the main points, but if I do not manage to do that, given the hour, I will of course be pleased to review the points raised and pick them up—in particular, looking at how I could be more helpful in providing some of the broader information that is being sought.
Perhaps I could start by emphasising that the whole point about the Bill is that Ministers are, of course, responsible to Parliament for how they discharge all their duties, including how they promote the comprehensive health service that we all seek and how we reduce health inequalities in access and outcomes.
The regulations prescribing the services retained for national commissioning will be subject to parliamentary approval. I assure your Lordships’ Committee that, in putting forward the regulations, Ministers have to have regard to patient numbers, provision costs and the number of providers, because they all relate to safety, effectiveness and value for money of commissioning at various different tiers.
(1 week ago)
Lords ChamberMy Lords, perhaps I may start by warmly welcoming the noble Baroness to the Dispatch Box. We wish her well.
This has been a valuable debate on an issue that affects millions of people across the country. While the amendments before us take different approaches, they are united by a common concern that access to NHS dentistry remains increasingly difficult to secure. I particularly wish to speak in support of the amendment in the name of my noble friend Lady Coffey. At its heart lies a simple but important principle: access to dentistry should not depend on where a person lives or what they can afford. Few would disagree that oral health is an integral part of overall health, yet for too many patients access to NHS dental services has become a postcode lottery.
The duty proposed by my noble friend would place equity at the centre of decision-making. That is a principle which this House has supported on many other occasions in many other areas of healthcare. It is surely no less important when it comes to dentistry.
The amendment from the noble Lord, Lord Hunt, and the noble Baroness, Lady Pidgeon, also raises an important issue. One frustration for Parliament and for the public is that discussions about NHS dentistry are too often conducted in the absence of clear, comprehensive and consistent information. Regular reporting on workforce pressures, access, inequalities and unmet need would provide a valuable evidence base against which future progress could be measured and Governments held to account.
The amendment from the noble Baroness, Lady Pidgeon, addresses perhaps the most visible manifestation of the current problem: so-called dental deserts. Finding an NHS dentist has become extraordinarily difficult, if not impossible, in many parts of the country. Today, three in five adults are not accessing NHS dentistry. That is not a marginal problem; it is a challenge affecting communities across the kingdom. We now have areas of the country where fewer than four in 10 adults have seen an NHS dentist in the past two years. That should concern us all. It speaks not merely of pressures within the service but to growing inequalities in access to care.
Patients are travelling significant distances for routine treatment; being forced into the private sector, despite financial pressures; or presenting at GP surgeries, walk-in centres and A&E departments because they have nowhere else to turn. These are symptoms of a system that, despite the dedication and professionalism of the dental workforce, is struggling to meet public demand.
Improving NHS dentistry requires more than warm words. Good oral health is not a luxury; it affects children’s development, educational attainment and well-being. It affects people’s ability to work, to communicate with confidence and to maintain their dignity. Increasingly, we understand its connection to wider physical health and quality of life. At a time when we are rightly focused on prevention, reducing health inequalities and delivering care closer to home, dentistry must be part of that conversation. We cannot continue to accept a situation in which access to NHS dental services depends so heavily on geography, workforce shortages or the ability to pay. These amendments offer thoughtful and constructive ways of advancing that object.
My Lords, I am very pleased to respond to this group, following on from these Benches from my noble friend Lady Hyde, who I am delighted to be working with on this Bill. I am very glad that she made her debut on group 1 today. We look forward to hearing more.
I am in absolutely no doubt of the challenge when it comes to dental services and dentistry. I am also deeply conscious of the situation that we started from. I will refer to some of the points about improvements and the need for further improvements, but let me turn first predominantly to the amendments before us.
On Amendment 49 from the noble Baroness, Lady Coffey, I understand the good intention behind this amendment but do not believe that it is necessary, because under Section 1 of the National Health Service Act 2006, the Secretary of State will continue to have a duty to promote a comprehensive health service in England and that includes NHS dental services.
In addition, Clause 4 strengthens the statutory framework by amending the Secretary of State’s existing duties so that they must have regard to the need to reduce inequalities in access to health services across England. As the noble Lord, Lord Patel of Bradford, rightly said, that includes coastal communities as well as others. The duty that I referred to provides a clear statutory basis for considering geographical and other inequalities in access. A dentistry-specific duty would therefore duplicate the deliberately broader framework that the Bill establishes.
I can reassure the noble Baronesses, Lady Coffey and Lady Pidgeon—because the comments that I am about to make also relate to Amendment 216 in the name of the noble Baroness, Lady Pidgeon—that we are taking practical action to tackle dental deserts. I was grateful for the comments of the noble Lord, Lord Patel of Bradford, who made the point that the definition of a dental desert is rather more complex than just miles, or indeed numbers, and that is indeed the case. The practical actions that we are taking include introducing a package of reforms to address some of the most pressing issues that dentists and dental teams have been experiencing, and therefore the knock-on effect to patients. These reforms prioritise those with the greatest need and shift care away from clinically unnecessary check-ups.
On the matter of addressing dental deserts, we have, supported by some £11 million, brought in some 50 additional dental school places on top of the existing 809. It is interesting to note that the University of Porstmouth and the University of East Anglia are where these will be provided; we are going to train more dentists in the areas that need more dentists. As we know, throughout the medical professions, when you train in an area you are more likely to stay. I add that all NHS regions now have a dental school. We also have the golden hello recruitment incentive scheme, with payments to dentists of £20,000 to work for three years in areas that need them the most. As of July this year, 159 dentists had started working in the areas that needed their services the most.
Referring back to Amendment 216 in the name of the noble Baroness, Lady Pidgeon, I make the point to a number of the comments made that since July 2024 we have sought to rebuild NHS dentistry while being in no doubt of the challenge. In 2025-26, just under 3 million additional NHS treatments were delivered compared with the previous year, and around half of those benefited children. I very much share the concerns that noble Lords have described. It is totally unacceptable that the primary reason for emergency care for children is their very poor dental health. Children’s access now exceeds pre-pandemic levels, more adults are being seen and more dentists practise in the NHS, if we compare it with 2019-20.
I absolutely agree with the noble Baronesses, Lady Finlay and Lady Pidgeon, and other noble Lords, about the key role of prevention. That is exactly why, as the noble Baroness, Lady Finlay, said, we have brought in a toothbrushing scheme for young children, as well as fluoridation. We are seeking to tackle—if noble Lords will forgive the pun—the root causes. I cannot think of another word, but perhaps noble Lords will enjoy that anyway. It is important that we prevent as well as treat, for sure.
I turn to Amendment 213, tabled by noble friend Lord Hunt. We agree that transparency and accountability are essential to a properly functioning NHS dental system. However, the amendment risks duplicating existing arrangements. For example, the annual dental statistics help to identify problems and inform policy development, and I know that nobody present would wish to divert resources away from patient services. The whole focus of the Bill is on increasing Ministers’ accountability to Parliament, so I have no doubt of that happening.
I will pick up on some of the other points that were made, in more general terms. The noble Baroness, Lady Coffey, the noble Lord, Lord Lansley, and my noble friend Lord Hunt spoke about the dental contract and expressed concerns about the focus on units of dental activity, which I understand. I agree that reforming the dental contract is a key lever, and that is why we are working with the British Dental Association and other representative bodies to do just that. In addition to that contract, we are looking at how we can better use technology and boost the number of NHS dentists, as well as all the other areas that I have spoken to.
The noble Lord, Lord Patel of Bradford, asked about funding. I can confirm that the dental budget is worth around £4 billion, net of patient charges. The Government want to ensure that the ring-fenced dental budget is spent on the patients who need it most, and we need to maximise treatments for taxpayers’ money. I am pleased to say that we reduced the NHS dentistry underspend, which was standing at £392 million in 2023-24, to £36 million in 2024-25. That will make a major change to the provision of dental services. On the question from the noble Lord, Lord Patel, about the dental framework being developed by the Chief Dental Officer, I will be pleased to write with more detail on that.
I will pick up a few points in response to the noble Lord, Lord Young; where I cannot do so at the moment, I will be pleased to write to him. As I have mentioned, 4 million urgent appointments were delivered in 2025-26; that is 8.4% more than in 2024-25, and more than in any previous year under the current contract. We have now required high street dentists to deliver a minimum amount of urgent treatment as part of their contract. On the point about fluoridation, which the noble Baroness, Lady Finlay, also spoke to in terms of prevention, we are investing £136 million over five years to maintain existing schemes across England and fund the expansion to which the noble Lord referred across the north-east of England. Some 6 million people are already benefiting from fluoridated water, and this latest intervention is expected to reach an additional 1.6 million, to reduce tooth decay and inequalities in dental health.
The noble Lord, Lord Kakkar, talked about bringing together datasets to understand the impact of dentistry on broader health, which is a point I take. I will be pleased to look into that and write to him.
I thank the Minister very much for that detailed response. When she writes to noble Lords, can she specifically pick up the issue of capital funding? Lots of the places that I am looking at have a population with enough people to have complex problems, but not big enough to have infrastructure. We really struggle without some capital investment. As the noble Lord, Lord Lansley, said, we need some capital funds to set up some of these physical services to actually do the workforce training.
Yes, I will be very pleased to include reference to that. I would probably use the word more broadly—the infrastructure that is necessary to support the dental activity—but I take the point and I will do my best to assist.
My Lords, I thank the Minister for her comprehensive response. There is something in what she said about a dental team. Many noble Lords have talked about children. Dental therapists are unsung heroes and heroines who are perfectly qualified to undertake a lot of the work that has been mentioned today, particularly when dealing with children. The challenge is that too many dentists will not allow dental therapists to practise. I have asked them for reasons why, and there are certain things they cannot and are not allowed to do with NHS paperwork. Dentists also talk about liability, in terms of insurance.
We need to open this up much more widely. I encourage the Minister to speak to the Minister for Health Innovation, who I believe is responsible for dentistry, to see what more could be done. Too many children’s teeth, never mind older people’s, are just being ruined when they do not need to be. It does not need to be a dentist who goes into a nursery to look at these things; there are perfectly well-qualified people who can undertake that.
I will likely return to the issue of dentistry on Report, but, with that, I beg leave to withdraw my amendment.
My Lords, I am most grateful to noble Lords for their contributions. Indeed, we all share a determination to ensure that patients receive safe, timely care in the right place. I am grateful to the noble Earl, Lord Howe, for his brevity; I will also seek to focus on amendments, and I hope noble Lords will appreciate that the reason for that is so we can deal with the content of the Bill.
Amendment 50 in the name of the noble Baroness, Lady Coffey, raises the important issue of rural access to ambulance services. I confirm that ICBs already have a statutory duty to meet the needs of their local population and to have regard to the need to reduce health inequalities, with respect to both ability to access health services and outcomes. I can assure your Lordships’ Committee that the funding that ICBs receive for commissioning ambulance services is based on factors such as age and deprivation and is adjusted to reduce health inequalities. To the point on rural areas, this includes adjustments for longer emergency ambulance journeys. We have heard some statistics, but I confirm that the category 2 mean ambulance response time is, as of July of this year, three minutes and 35 seconds faster than in July 2024. That is not the end of the story; I am simply indicating progress that is being made. I recognise, as always, the challenge of the situation that we are dealing with.
On Amendment 229, tabled by the noble Baroness, Lady Pidgeon, I certainly share her determination to reduce long waits in A&E. Trusts are already expected year on year to improve four-hour performance and to reduce waits of 12 hours or more from arrival. There is no complacency about what we have to do to improve performance, which is why the Secretary of State recently announced £140 million of investment in urgent and emergency care schemes across England, including urgent treatment centres, same-day emergency care, emergency department upgrades and additional ambulance capacity.
We are also taking action across the urgent and emergency care pathway to reduce excessive waits and to improve patient safety and flow through hospitals, which the noble Baroness, Lady Finlay, spoke to. I assure your Lordships’ Committee that this will continue following the abolition of NHS England. It is our view that a legal time limit in itself would not address the underlying pressures on capacity and patient flow that contribute to long waits, and establishing a new statutory scheme would risk distracting from the crucial work that is already under way.
On Amendment 219, also tabled by the noble Baroness, Lady Pidgeon, I could not agree more that corridor care must not—not even should not, but must not—be normalised. I am reiterating some of the points that I made in a recent Oral Question, which I believe was from the noble Baroness, on this very important point. Our priority is sustained action to address the causes by improving patient flow and discharge, expanding urgent care capacity and supporting the most challenged hospitals. We have introduced a consistent national definition and reporting arrangements, and we have improved transparency and enabled support to be focused where it is most needed.
The Secretary of State has also asked NHS England to bring forward urgent plans aimed at eliminating corridor care for children. I can say that one in six trusts consistently reported no corridor care across their emergency departments or the wider hospital over the summer. I particularly make the point about the summer because of the extreme pressure due to the weather—not something we usually say, but we are increasingly seeing it. The pressures were immense, and that was their report to us.
The noble Baroness, Lady Finlay, made the strongest case for exactly what we are doing with the neighbourhood health service, which is about moving the focus from hospital to community. I spoke earlier this week in the Chamber about the movement of savings accruing from timely discharge that can be directed to neighbourhood health. We are trialling that, because it is a very clear and practical way to make the move that the noble Baroness rightly identifies.
Baroness Pidgeon (LD)
My Lords, may I tease something out that the Minister was saying about corridor care? She quickly moved on to another thing, and I wanted to come back in.
Yes, this is similar to a discussion we had only last week or the week before in answer to a Question I had tabled, but two-thirds of medics working in emergency departments are saying that their trusts are not accurately reporting the data on corridor care. The Minister keeps saying that we have this new definition or whatever; it was decades ago that I worked in the NHS, but we had a way to make sure that people were not counted as being on a trolley: you took the wheels off and it became a bed. Trusts are very creative at finding ways around to meet their definitions. If two-thirds of those surveyed by the Royal College of Emergency Medicine are reporting that their trusts are not accurately calculating this, what are the Government doing to try to get under the data, to make sure that the Minister and the department are getting accurate data to be able to deal with this serious problem?
I feel quite sure that the noble Baroness herself never did such a thing.
I take very seriously the point that the noble Baroness made. I am sure it is already being looked into, but I will personally make sure that that is the case.
On corridor care and children, one example of the practical action taken is our recent announcement that the NHS is rolling out a standardised system to spot when a child’s health is deteriorating, so that early warning signs are caught earlier and there is faster action. The paediatric early warning system will be introduced in all emergency departments by the end of 2027-28, with an ambition to also roll this out in ambulance and community settings in the future. This is broader than just corridor care, but I know that that is a particular concern, as I said, when it comes to children. I cannot confirm often enough that we remain committed to fully eliminating corridor care before the end of this Parliament.
Finally, on Amendment 72, in the name of the noble Lord, Lord Patel of Bradford, I can give the reassurance that there is no national policy supporting blanket minimum waits. Indeed, patient safety always comes first. If a commissioner puts capacity measures in place, urgent referrals must be excluded, minimum waits must not be set above 18 weeks and providers must continue to triage patients according to clinical priority.
At the start of the year, it is important and expected that commissioners plan to balance service delivery with their yearly budgets while prioritising patient safety and clinical need. I remind your Lordships’ House that it is due to our approach to financial planning that the NHS stayed in line with its budget in 2025-26 while also cutting waiting lists by over 250,000 between July 2024 and August 2026. Removing the use of tools to support planning could drive unplanned activity and overspending, which would of course undesirably divert resources from other patients.
On the points made by the noble Lord, Lord Patel, about autism and ADHD assessment, expectations have already been set out for ICBs and providers to reduce those long waits and to improve experience, quality and productivity in ADHD services over the next three years. We are moving to a needs-led support model that means earlier access to information and support and appropriate interventions that are individually based, without and before a diagnosis.
On the question about ICBs imposing minimum waits and whether we will publish which ICBs are doing this, there are no plans to publish this information. The data is held locally and that is right, because these are decisions for local areas. To restate what I said before, commissioning decisions are for ICBs to make.
The Minister just made a very important point. Can she clarify? Is she saying that there is a requirement for ICBs to statutorily report that they have implemented a minimum wait standard, or not?
The question from Lord Patel was about whether there were plans to publish this information, and I was explaining that there are no plans and the reasons why.
Going back to the analogy of taking the wheels off the beds, it feels as if ICBs have certain budgets they want to spend on certain things and they are creating criteria that exclude vulnerable people. This is really important. All I am asking is, are the Government not looking at the more than 50% of ICBs that have put in minimum waiting times without assessments? If they are not assessing that information or looking at the data, how do they know what ICBs are up to? It is not about publishing it—okay, I suggested that we should publish it; it is about examining what these ICBs are doing and what the potential dangers are. I heard the conversation that said, “These are our criteria”. While our clinicians are saying that these people are at risk of suicide, they are saying, “These are our criteria”.
I am glad that the noble Lord understands the reason why the Government are not seeking to publish, which was the question I was being asked about. For me, this is a question about the accountability of ICBs, currently held accountable by NHS England. But the whole purpose of the Bill is to improve the quality of accountability after the abolition of NHS England.
I just have one last point, and I am conscious that people have said that we do not want to take this too far. Will the Minister reflect on the issue and the principle that somebody who requires treatment or assessment should not have to wait for purely financial or administrative reasons, even though there is a clinical need?
I have already made reference to what the priorities are: need and patient safety. I assure the noble Lord that I reflect on everything noble Lords say, and I certainly believe that I have already given that assurance.
My Lords, this group of amendments has been informative, as have noble Lords’ contributions. I think that the noble Lord, Lord Patel of Bradford, may be referring to situations where a minimum is being deployed for people who have expressed their view that they would like to use an independent provider to tackle the issues, and I think that something is not quite right there. But we also have to be realistic. NHS England and all the trusts have to live within their means and not every area can be bailed out, as continues to happen at the Nottingham University Hospitals Trust and the Liverpool University Hospitals NHS Foundation Trust, which is in the recently published figures.
Obviously, whether it is about an ambulance or going to an urgent treatment centre or SDEC, I am conscious that the philosophy in the NHS up until fairly recently was that it was very proud that it had far fewer beds per person on average compared to other parts of Europe, on the basis that people would often get their operation, be dealt with and go home safely that same day. Thus, the thinking was that not quite so many beds were needed.
I welcome the reference to Sir Chris Whitty’s report, particularly in the context of rural communities. But without further ado, I beg leave to withdraw my amendment.
(1 week, 1 day ago)
Lords ChamberTo ask His Majesty’s Government what assessment they have made of the effectiveness of neighbourhood health services in improving patient outcomes and reducing pressure on hospitals.
My Lords, the success of neighbourhood health will be measured against the national goals in the neighbourhood health framework, including improved health outcomes and better urgent and emergency care performance. Early local reported evidence from neighbourhood health approaches is encouraging, including reported reductions in emergency department use and in emergency admissions. The learning from the 43-place national neighbourhood health implementation programme is informing wider implementation, alongside an independent national evaluation commissioned through NIHR.
I am grateful for that response from the Minister. Can I ask about the example of heart valve disease, which affects one in 15 people over the age of 75? Of those, half go undiagnosed, which can lead to severe illness, hospitalisation, expensive treatment and, unfortunately, avoidable early mortality. We have digital diagnostics available in the community now which, in the hands of GPs and pharmacists, can enable much of that lack of diagnosis to be met and therefore preventive treatment to be successfully applied. What are the Government doing to enable the spread of diagnostics into the community, which is vital in that transition from hospital to community, from treatment to prevention and from analogue to digital?
The noble Lord comes forward with a good example; digital diagnosis is a huge support in the improvements that we seek to make for patients, so we are investing in digital diagnostic transformation through NHS England’s diagnostics digital capability programme. That will ensure that networks have that core set of digital capabilities so that care can be improved in quality, safety and productivity. Those are all outcomes that we seek in neighbourhood healthcare.
My Lords, the noble Lord, Lord Lansley, has underpinned the importance of general practitioners. My noble friend will be aware that there is a big variation in the number of GPs per patient up and down the country. Can she say a little about what the Government are doing to deal with these under-doctored GP areas?
It is true that general practice is a cornerstone of neighbourhood health. I am glad that people will now find it easier to access their doctor and have more choice in how and when they book appointments. With reference to digital access, I believe that will greatly help in accessibility to GPs, but we are improving capacity. We are employing more GPs; there are now 2,800 more fully qualified full-time equivalent GPs employed compared with July 2024. That is the highest number since 2015. We have also made changes to the GP contract so that PCNs and practices can hire more GPs and introduced a practice-level GP scheme. We are focusing our efforts on the more under-doctored areas that my noble friend describes.
Baroness Pidgeon (LD)
My Lords, we cannot expect neighbourhood health services to succeed without ensuring that resources shift from hospitals into the community, so can the Minister set out how much additional NHS funding will be directed towards primary and community care, and how this will be monitored?
My Lords, joined-up care requires changes to funding flows in order that we can shift our resources. That is where the focus will be. I am glad that from next year we will be trialling for neighbourhoods and places payment mechanisms which mean that savings from reduced unplanned hospital care can go into increased investment in community services. That will not only provide extra funding in terms of neighbourhood health but drive change, which is what we are seeking. In addition, we announced in the Budget 250 neighbourhood health centres, with 120 delivered by 2030, and the first wave of 27 sites comes with a commitment of £50 million.
My Lords, given that 97% of emergency departments feel that the current pressures on them are unsustainable through the winter, when will the Government establish seven-day services in the community so that bed occupancy rates can fall from their current 93.4% to 85%, which is much safer and will allow emergency departments to deal with really major emergencies and trauma?
By expanding urgent community care, we will reduce avoidable emergency department attendances, hospital admissions and ambulance conveyances. That is why we are engaging not just an urgent community response but virtual ward services. I also point to the fact that we are supporting patients to book the most appropriate urgent care service through NHS 111 or the NHS app before attending emergency departments. There are a number of very good examples around the country of how people are doing that. Winter is going to be hugely challenging, and that is why, for example, we are putting in £190 million to help the NHS manage winter pressures and £140 million for new urgent care schemes.
My Lords, we all agree with the shift from hospital to community but, as we discussed on the Health Bill in Committee last night, we are still waiting for details of how it will all fit together. Can the Minister explain whether existing primary care providers, especially local GP practices, will be expected to rebrand as neighbourhood health centres and maybe offer some additional services, particularly secondary services, or will existing GP practices be told to physically move from their current premises into a neighbourhood health centre, and how will they be consulted?
We are supporting ICBs, providers and everyone across the NHS to work together differently. That is the main point I want to get across. In March this year, we published Fit for the Future: Towards Population Health Delivery Models, which set out three new population-based contract types. They aim to bring various aspects of services into a single contract, and they will deliver a shift from what is currently fragmented, service-by-service commissioning to end-to-end pathways around the patient. That is where we need to get to. GPs are very much part of that, and we have involved them throughout.
My Lords, we cannot have neighbourhood health without having more community nurses, yet the majority of nurses are in the acute sector, so what are the Government doing to increase the number of community nurses?
The noble Baroness will be aware that the Secretary of State has confirmed that the workforce plan will be published in the new year. It will take account of that point and the new way of working—how we build the NHS into the future around patients. The point that she makes is quite right. The workforce plan will set out how we will do that.
My Lords, I draw attention to my declared interest as chairman of King’s Health Partners. Section 131 of the 2006 NHS Act requires NHS England to ensure that it has been properly professionally informed in determining how to provide diagnostic, preventive and treatment health services and public health services. It is proposed that this obligation will no longer apply to the Secretary of State when NHS England is abolished. How do His Majesty’s Government propose to ensure that proper, clinically informed information is available in determining the provision of local health services in the future?
As I recall, we discussed last night in the Health Bill the establishment of a clinical council which could guide and advise the Secretary of State, who is, of course, ultimately responsible.
My Lords, community pharmacies are a key pillar of neighbourhood health services, providing treatment for small illnesses and as part of the vaccination programme. Can my noble friend the Minister outline what plans the Government may have to extend and expand the vaccination programme to community pharmacies?
My noble friend is quite right that expanding the availability of NHS vaccinations through community pharmacy is very much the way forward. That is why in the last flu season we enabled the provision of flu vaccinations through pharmacists to two and three year-olds. It is why in this flu season we are extending that still further, to children and young people in clinical risk groups and for catch-up vaccinations. We have also piloted delivery of the RSV vaccination for older adults and pregnant women, which my noble friend has campaigned on very successfully.
(1 week, 1 day ago)
Grand CommitteeThat the Grand Committee do consider the Tobacco and Vapes Act 2026 (Display of Tobacco Products) (Consequential Amendments) Regulations 2026.
My Lords, I shall speak also to the draft Tobacco and Vapes Act 2026 (Age Verification Defence to Underage Sales) (England and Wales) Regulations 2026.
The Tobacco and Vapes Act, which received Royal Assent earlier this year, was landmark legislation that will deliver on the Government’s commitment to create a smoke-free generation and tackle youth vaping. As we know, smoking claims around 75,000 lives a year in the UK. That is why from 1 January 2027 it will be an offence to sell tobacco products, herbal smoking products or cigarette papers to anyone born on or after 1 January 2009, which will help to create the UK’s first smoke-free generation. The Act has also strengthened protections for children by making it an offence to sell vaping products or nicotine products to anyone under the age of 18, closing loopholes in the previous age of sale requirements. This reflects our health advice that, while vapes can be an effective aid for adult smokers to quit smoking, children and non-smokers should never vape or use nicotine products.
The two instruments before the Committee today will support the effective implementation of the new age of sale measures in the Act. I begin with the age-verification regulations. The Act provides powers to set out in regulations steps that retailers may take to verify that a customer has reached the legal age of sale, as a defence to the age of sale offences. This instrument sets out the steps that would satisfy this defence in England and Wales. It aims to give retailers confidence about how they can verify the age of customers attempting to buy these products. It also provides for two alternative methods of age verification which will both satisfy the defence.
First, a person charged with an age of sale offence may rely on the defence where they can prove that they were shown a physical identity document bearing the customer’s photograph, a date of birth and a holographic mark or ultraviolet feature. These criteria capture common forms of ID such as passports, driving licences and PASS cards. Secondly, a retailer may rely on a digital proof of age. This must be verified and delivered through a digital verification service, known as DVS, which has been independently assessed against the UK DVS trust framework and is listed on the statutory DVS register.
The provisions on digital proof of age follow the passage of the Data (Use and Access) Act 2025, which placed the trust framework and the DVS register on a statutory footing. They also follow the coming into force of the Licensing Act 2003 (Mandatory Licensing Conditions) (Amendment) Order 2026, which enables the use of these services as part of alcohol sales. I shall be clear that there is no requirement for individuals to use digital proof of age, nor are businesses required to accept it. It simply provides an additional, voluntary option alongside physical documents.
In developing the criteria for physical and digital proof of age, we have considered three key aims. First, we have sought to mirror the criteria for physical and digital proofs of age that can be used for alcohol sales—something we rightly discussed in Committee. This aims to capture the many retailers who sell alcohol as well as tobacco, vaping and nicotine products, who will need to remember only one set of criteria. Secondly, the criteria ensure that a range of commonly used forms of ID can be accepted. Thirdly, we have sought to future-proof the regulations by ensuring that digital proof of age can be used alongside traditional physical documents. In other words, we are seeking to make this workable.
Neither the Act nor these regulations create a requirement for retailers to ask every customer for proof of age before every sale. The steps set out in this instrument are also not the only means of establishing a defence. The Act provides an alternative defence where a retailer can prove that they took “all reasonable steps” to avoid committing the offence. This is very much a re-enactment of the defence in previous tobacco and vapes legislation of having taken all reasonable precautions and exercised all due diligence. These regulations set out an additional, more prescriptive route to establishing a defence. A retailer who follows the steps in these regulations can have confidence that they would be able to demonstrate a statutory defence if they were ever subsequently challenged over a sale—another matter that arose, correctly, during Committee.
The next statutory instrument I will refer to relates to the display of tobacco products in retail premises. Under the current rules, introduced by the Tobacco Advertising and Promotion Act 2002 and related regulations, retailers in England, Wales and Northern Ireland are prohibited from displaying tobacco products. The 2002 Act includes an exemption that allows retailers to display tobacco products to a customer aged 18 or over, on their request, and a linked defence where a retailer mistakenly displays products to someone whom they reasonably consider to be 18 or over. This statutory instrument updates those provisions so that tobacco products can be displayed, on request, only to people born before 1 January 2009, aligning display restrictions with the new age of sale that comes into force on 1 January.
Without these amendments, under the current display legislation, individuals aged 18 and over could still be shown tobacco products, even if the products could not legally be sold to them. This would undoubtedly create an inconsistent and confusing position for retailers and could increase the risk of accidental underage sales. By aligning the age at which customers can be shown tobacco products with the new age of sale, we are aiming to help businesses comply with the law and to support effective enforcement.
These changes also aim to ensure the continued effectiveness of restrictions on tobacco display. We have decades of evidence to show that reducing the visibility and accessibility of tobacco products helps to reduce their appeal, particularly among young people. Restrictions on display also contribute to a more supportive environment for adults who are trying to quit smoking, by reducing exposure to tobacco products in everyday settings.
These regulations mark what I believe to be an important milestone in the implementation of the Tobacco and Vapes Act. They are a step towards creating a healthier future for today’s children and for generations to come, and I commend them to the Committee.
My Lords, I thank the Minister for introducing this SI and for turning up this morning. She is clearly under the weather; perhaps she should have a hot toddy and take a rest for the rest of the day, given that she will be in her place at the Dispatch Box tomorrow evening for Committee on the Health Bill.
Protecting young people from the harms of smoking and vaping is the principle underpinning both these measures, but it is essential that the regulations implementing these changes are practical and properly scrutinised. The first instrument I will address today concerns the display of tobacco products, aligning existing exemptions with the new generational ban. At first glance, this appears to be a straightforward change, but it raises wider questions about the cumulative burden being placed on retailers.
The Government’s own impact assessment estimates that the changes to vape displays could cost retailers £26 million. The Association of Convenience Stores has suggested that the costs of a full display ban could actually exceed £160 million for convenience stores alone. These figures demonstrate the substantial financial pressures facing businesses as a result of these reforms. Can the Minister therefore clarify what assessment has been made of the specific costs associated with implementing this instrument, particularly for small independent retailers? What assurances can she provide that businesses will receive sufficient time and guidance to adapt?
The second instrument sets out the steps that retailers must take to check a customer’s age when selling tobacco or vaping products so that they can demonstrate that they have followed the law if an underage sale takes place. These provisions follow on from the fact that the generational ban introduces a fundamentally different approach to age verification. Rather than simply establishing whether someone is over 18, retailers will need to determine whether customers were born before a particular date: namely, before 2009.
This creates additional complexity for shopkeepers and their employees, who will be expected to understand and enforce the law. The Government must ensure that those acting responsibly are not inadvertently exposed to prosecution because of unclear requirements. Can the Minister explain how the Government will ensure that retailers can reliably check whether a customer is legally entitled to buy tobacco, particularly as the age limit will change each year? What expectations are there for people to carry identification as they get older?
During the passage of the Tobacco and Vapes Act, concerns were raised about the extensive powers given to the Secretary of State. Concerns have been repeatedly raised about the breadth of the Government’s regulation-making powers and the importance of parliamentary scrutiny. It is therefore vital that these powers are exercised transparently, with clear evidence supporting the measures introduced. Can the Minister tell us how the Government expect trading standards officers to enforce these additional requirements without providing them the resources to do so?
As my noble friend Dr Caroline Johnson highlighted in the other place, these powers could allow the Government to extend smoke-free restrictions to a wide range of places with limited parliamentary oversight. While these SIs deal particularly with tobacco displays and age verification, the wider concern about scrutiny remains. Can the Minister reassure the Committee that future regulations will be subject to proper consultation and parliamentary scrutiny, and that the Government will clearly explain why further restrictions are necessary?
I hope the Minister will address these concerns and reassure the Committee that these regulations will be implemented fairly and scrutinised properly.
My Lords, I am most grateful to all noble Lords who have contributed to this debate and grateful for the support for the measures that we are taking. I know that many noble Lords who have spoken today have long been active campaigners, and I am extremely grateful. In particular, the noble Lord, Lord Young, welcomed the various steps across government, which speaks to the fact that this is not just a matter for health; there are other actions that we can take. I am also glad that the noble Lord, Lord Rennard, welcomed the clarity that these regulations will provide. He referred to avoiding unnecessary friction. That was very much part of our discussions during the passage of the Bill, and it is one of the concerns of the noble Lord, Lord Evans, which we share.
In just seven weeks’ time, the smoke-free generation will become a reality in this country, and that is something to celebrate. The first young people born in 2009 will turn 18, the law will change and those young people will enjoy a life that is free from the harms of tobacco that have plagued successive generations before them. These two sets of regulations are important steps in making sure that retailers are ready—I take on board the concerns raised—that the law is consistent and that the new age of sale is implemented successfully from 1 January. That is what these regulations seek to do.
I turn to the points raised. The noble Lords, Lord Young and Lord Rennard, raised questions about the tobacco industry’s influence and input into consultations. I remind the Committee that our consultation on proposals to reduce the appeal of tobacco, vaping and nicotine products closed on 2 October. The consultation spoke to aligning the display of vaping products, nicotine products, cigarette papers and heated tobacco devices with display restrictions—in other words, removing them from display and moving them away from the eyes of children and young people. We are currently considering the responses.
Concerns were raised about interference. We have robust controls in place to prevent the manipulation of public consultations. These controls certainly worked effectively in our past consultation, where we set out the case to create a smoke-free generation. I assure noble Lords that we remain alert to the kind of interference raised by the noble Lord, Lord Young, in particular, and we will not be deterred from doing what is necessary to promote healthier living and to protect children and young people.
The noble Lord, Lord Young, asked about a road map. Of course, we very much share the ambition to further drive down smoking rates; we are far from complacent. I know how pleased the Chief Medical Officer was recently at the historic low in smoking rates, but we do not stop there; we will continue. Our immediate priority is delivering the Tobacco and Vapes Act and the comprehensive programme of secondary legislation that sits behind it. With the investment in stop smoking services and enforcement, these measures will form our programme for delivering a smoke-free UK.
It might be helpful if I remind the Committee that the Act includes a requirement for the Secretary of State to review the operation of the Act within four to seven years of Royal Assent and to lay a report before Parliament concluding the findings of this review. I assure noble Lords that we remain open to evaluating the impact of the Act and to being held to account on that. I remember the conversation about what the right length of time was. This is our feeling on the right length of time, so we can give the Act time to make an impact and be realistic with Parliament about what has been achieved.
Before the Minister sits down, can I ask her a little more about this promotional campaign beginning on Monday? What is the budget for this campaign? I am delighted to hear that it will appear on television, radio, social media and elsewhere, but these things cost, and I would like to know how much will be invested in this programme. Perhaps the Minister could let me know another time.
I will be very pleased to write to the noble Lord on that point of detail.
(1 week, 1 day ago)
Grand CommitteeThat the Grand Committee do consider the Tobacco and Vapes Act 2026 (Age Verification Defence to Underage Sales) (England and Wales) Regulations 2026.
Relevant document: 13th Report from the Secondary Legislation Scrutiny Committee
(1 week, 2 days ago)
Lords ChamberMy Lords, it is unacceptable that women spend more years in poor health than men, while pain is too often dismissed and normalised. Our renewed women’s health strategy treats this as a systemic failure, and this research reinforces that. Patient-reported measures will be introduced in gynaecology services to assess whether women’s pain is heard and effectively treated, alongside testing patient power payments, which will be linked to women’s feedback, including their experience of pain.
Baroness Nargund (Lab)
My Lords, I thank my noble friend the Minister for her reply. This large international study has found that more women report pain across 11 body sites compared to men, and over half of them report that their pain has been either ignored or dismissed by healthcare professionals. Given that pain is a leading cause of disability and reduced economic participation, can my noble friend tell us what concrete steps the Government are taking to tackle the gender pain gap and the gender pain management gap, and what actions will be taken if healthcare professionals continue to ignore or dismiss women’s pain?
My noble friend’s observations are quite right. We have already updated NICE guidance and introduced courses in order to strengthen professional education across a range of conditions. We have introduced targeted initiatives, including the Getting It Right First Time chronic pain workstream. Our introduction of Jess’s rule and Martha’s rule will mean that women can challenge when symptoms persist or they feel that they are not being listened to. We are developing a new multiprofessional capability framework for women’s healthcare in community settings, and that will address a pattern of women’s symptoms being dismissed or normalised.
Baroness Pidgeon (LD)
My Lords, the Government’s women’s health strategy pledges to eliminate the diagnostic issues for women with endometriosis. In the light of Emma Barnett’s recent BBC documentary and Endometriosis UK’s finding that women wait an average of nine years and four months for a diagnosis, will the Minister support the charity’s call for diagnosis times to be reduced to one year or less by 2030, and commit to publishing national data to track progress?
Women are waiting far too long, which is the reason for the renewal of the women’s health strategy. We have, through the National Institute for Health and Care Research, commissioned a number of studies which are very much focused on the points that the noble Baroness is raising, which are endometriosis diagnosis, treatment and, importantly, experience. We have committed over £4.3 million for new research projects, including a trial to evaluate the effectiveness of pain management programmes, and the noble Baroness will be aware of our commitment for waiting times to be reduced in order that patients, including those with endometriosis, can know exactly what to expect.
My Lords, the Minister said that women’s pain and pain management will be addressed by the forthcoming women’s health strategy. What specific goals and objectives have been set and what accountability will there be if those goals and objectives are not met?
Action 4 commits to testing patient power payments, and we are prioritising gynaecology services as a test. That will mean that if a woman’s feedback, which will be actively sought, is not what it should be based on their experience—and that includes pain—then payments can be withheld and invested to improve the situation. I am sure the House appreciates that often it is finance which drives change, and this is just one of our new ways of doing that.
My Lords, does the Minister agree that the country needs to target the poorest members of our community, male and female, whose health is worse than the average and who need the resources that we require?
I agree with that. That is why, in the 10-year health plan and in our manifesto commitments, we are working towards the commitment to halve the gap in healthy life expectancy between the richest and the poorest regions, and setting a minimum standard of healthy life expectancy of 61 years in all areas. That is consistent with halving the gap, and means that we will give attention to all regions of the country, particularly those that need it most.
My noble friend will not be surprised that I ask about osteoporosis. Not only are the fractures themselves painful but so too is the recuperation, and it is particularly women who are affected. As my noble friend knows, I am still awaiting a little more reassurance from the Government. Maybe she could tell us the moves that they will make on this.
As I have previously committed to and confirmed, as my noble friend will be aware of, the 10-year health plan reaffirms the commitment to rolling out fracture liaison services by 2030 as part of more devolved health services. We continue to work with integrated care boards to make that happen, while investing, for example, £2.6 million in 20 new state-of-the-art DEXA scanners, building on the first wave of investment of £1.9 million in 13 of the scanners last year.
My Lords, recent reports have shown a clear lack of awareness and understanding of women’s reproductive health conditions among primary health care practitioners. Other reports have cited that what is needed is to remove the stigma and for there to be more training and awareness, so that women across the country, wherever they live and whoever their GP might be, can expect the same level of support and pain relief should they need it.
I certainly agree. Looking back at the 2022 women’s health strategy, 84% of women experienced not being listened to by a healthcare professional. As I have already stated, that is totally unacceptable. A third of those women said that this had harmed their mental well-being. This is a very serious matter and that is why we are strengthening professional education across a range of conditions, testing out the patient power payments and introducing patient reported-experience measures. All those should drive improvements of care over the next five years, some more immediately than others.
My Lords, one of the commendable objectives defined in the 10-year health plan is the development of women’s health centres. Can the Minister confirm that these will be not just advisory centres but diagnostic and, if possible, treatment centres, and that they will be appropriately staffed and funded?
The centres will very much take a multidisciplinary approach, not least because they are about seeing women as a whole rather than as a condition. That is the big change we will see. It will inspire change across neighbourhood health services, not just in respect of women.
My Lords, does my noble friend agree that even where chronic pain has been identified in women, or in men, there is often considerable reluctance to accept the available treatment, because long-term pain is very often treated with drugs which have quite significant side effects? Can my noble friend say what work is being done, possibly supported by the health service, to develop pain relief strategies which do not create those side effects?
Women are certainly more likely to experience multiple long-term and limiting conditions, and with that comes pain. In addition, we are absolutely committed to ensuring that there is a standard of care for, for example, gynaecological procedures such as hysteroscopy. We have consulted with the Campaign Against Painful Hysteroscopy for women with lived experiences around painful procedures, and we have gathered their insights. That is an approach we will continue to take as we develop pain management pathways across a whole range of conditions.
(1 week, 2 days ago)
Lords ChamberMy Lords, in responding to this group, I will endeavour to set out how we expect the Secretary of State to act and our overall approach to this topic. I am doing that because I hope it will be helpful not just in this group but in the next one, which relates also to the power of direction. I appreciate the understanding of my noble friend Lord Hunt and the noble Baroness, Lady Coffey, in seeing the practical way that the Bill is seeking to work—in the round, I might add. That is what has struck me about this valid debate to unpick what the Bill will do.
With permission, I will address all the amendments in relation to Clauses 8, 11 and 21 together in this group. On Amendment 47, tabled in the name of the noble Lord, Lord Patel, I can confirm that the Secretary of State will continue to routinely obtain appropriate advice to inform all decision-making, and they will have access to a wide range of clinical, scientific and public health expertise. That will ensure that decisions are informed by professional and clinical insight—for example, from the Chief Medical Officer, the Chief Nursing Officer, standing expert committees and ad hoc advice. To further strengthen clinical leadership across the system and advice given to Ministers on the NHS’s major clinical priorities in the health and care system, which is a matter that has come up a number of times, we will establish the first clinical council. This will bring together a small group of senior clinicians to strengthen leadership, and their experience of treating patients and improving services will directly inform our decision-making in those areas.
Before moving on, I want to briefly mention Amendments 30 and 31, tabled by the noble Lord, Lord Scriven, which reference Clause 8 of this Bill. The power in this clause is distinct from the general power of direction in Clause 11, and allows the Secretary of State to direct integrated care boards to exercise functions on their behalf. While the ICB will be legally responsible for discharging a function, the Secretary of State remains accountable for it, may place restrictions on onwards delegation and must publish any directions. This measure empowers appropriate, flexible local service planning by the Secretary of State to assign functions to ICBs, in the way we see them developing.
On Clause 11, I will address as a group Amendment 39, tabled by the noble Baroness, Lady Bennett, and Amendments 40, 55, 56, 69, 76, 77, 114 and 117, tabled by the noble Lord, Lord Scriven. This clause establishes a general power for the Secretary of State to direct integrated care boards in the exercise of their functions, including directing a single ICB, a group of ICBs or all ICBs. If we reflect on the 2012 Act, as I think we should, the fact is that it was overcomplicated. When it comes to practice, it has been harder to respond to challenges, not easier—which is where we want to get to. It is important that Ministers have the humility to recognise what they cannot foresee, and that it is just not possible to legislate for every situation. I believe that it is crucial to have flexibility to meet these challenges when they emerge. The Bill returns us closer to the pre-2012 situation, when—as a number of noble Lords have observed throughout the passage of this Bill—the public expected Ministers to be able to intervene, but expected them to do so sparingly, and Ministers had the necessary powers required.
Over the years, Ministers have had to respond to emerging circumstances, and the noble Lord, Lord Scriven, asked for examples. I reflect back to the fact that Ministers in 2012, for example, did not anticipate having to respond to the situation in the Mid Staffs NHS Foundation Trust, nor could they have predicted challenges to existing contracts in the NHS coming about following the invasion of Ukraine. I am sure that there are many other examples that we could look to. The noble Lord also made reference to subordinate legislation. My reading of that is that it is very much a technical term, including orders, rules, schemes and regulations authorised by this legislation. It is usual for those not to be subject to parliamentary procedure. I confirm to the noble Lord that we can commit to sharing examples of developing drafts of directions as soon as possible.
Looking forward, the power that we are looking at here will be particularly important as ICBs take on a wider set of commissioning responsibilities from NHS England. We intend to use directions more routinely to support the system; for example, in setting standards for specialised services and establishing reporting standards to measure progress—all things that noble Lords, regularly and rightly, press me to ensure are in place. The noble Baroness, Lady Coffey, gave some examples of where powers of direction could be used in addition to the point that I have already made. They are indeed ones that could be addressed by the use of the power of direction.
This clause also includes important limits on the scope of the power. I emphasise that, as a number of noble Lords have expressed concern about it. The reality is that the Secretary of State will not be able to direct ICBs to appoint specific individuals nor to direct the use of a drug, treatment or diagnostic technique that conflicts with NICE guidance or recommendations.
The noble Lord, Lord Stevens, asked about the NICE exception. The Bill reflects that NICE has not made recommendations in relation to a number of treatments and services. It is important to allow the Secretary of State to issue directions in that absence of recommendations in relation to more specialised services commissioned by ICBs.
The noble Earl, Lord Howe, asked where responsibility ultimately lies when things go wrong. As I think all sides of the House know, the ultimate responsibility is with the Secretary of State, and there is no movement on that. Ministers have to act reasonably with directions. Directions will be challengeable in courts and Ministers will ultimately be accountable to Parliament for their use. Directions will be required to be made in writing and to be published as soon as reasonably practicable.
The noble Lord, Lord Scriven, raised a question about scrutiny of some regulations. There may be a need to act quickly. In that situation, as I have said, directions will be published, and Parliament can scrutinise. The Delegated Powers and Regulatory Reform Committee, which the noble Lord referred to, has reported on the Bill and did not challenge this.
Moving to Amendment 39, I can assure the noble Baroness, Lady Bennett, that existing legislative checks and balances on local commissioning decisions will continue, such as having regard to the need to reduce health inequalities and to ensure patient choice. Directions cannot be used to undermine those duties. The intention with this power is not to micromanage the system but to be flexible and reasonable, and for it to be used for the benefit of patients and the public as new commissioning approaches develop. Despite the intention of the amendment, I fear that it works against such flexibility, which I suspect is not the intention of the noble Baroness, Lady Bennett. We do not expect to use this power to constrain ICBs when selecting providers. However, the public expect Ministers to be able to intervene if they need to protect patients and the public.
I think the bigger question that the noble Baroness is asking is about politicisation; I heard what she and the noble Lord, Lord Stevens, said about the situation elsewhere. I have to remind myself that, if there were, for example, a different Government with whom I did not agree—goodness me—it would be their right to make decisions and bring forward legislation. So, with the best will in the world, whatever we do here, we have to be realistic about what we can achieve. It is also important to note that checks and balances, which I have referred to, are already in the system. We are doing the opposite of tearing them up: we are continuing to apply them.
In the case that the noble Baroness raised, the issue is that of course we have an Independent Reconfiguration Panel but, ultimately, it should be the Secretary of State’s decision. Otherwise, we would have a situation where a decision to close a service in a locality would be made not by those elected by local people but by an appointed board. Surely, in the interests of democracy and accountability, the Secretary of State must in the end have that intervention power.
My noble friend has put it very clearly and I most grateful. I think the public believe that the Secretary of State has that power already, but in fact she does not, which is a point my noble friend has made on many occasions.
Turning to Amendment 40, I should also draw attention to the distinction we have made between the more routinely used power of direction and the powers specifically reserved for use in cases of significant failure or risk of significant failure. Retaining the distinction between types of direction is important, as is the recognition of when an intervention is undertaken to protect patients, the public or taxpayers. I note the alternative proposal to appoint commissioners from the noble Lord, Lord Scriven, in Amendment 40. My concern is that this approach would likely be more cumbersome and would slow Ministers’ ability to intervene where significant failure was occurring—something that I know noble Lords would not want. Amendment 40 also touches on outcomes frameworks. I assure the noble Lord that I share the sentiment about the importance of outcomes frameworks, and, if necessary, we can complement existing frameworks by using directions.
I will now briefly touch on Amendments 76 and 77, which relate to Clause 21. The clause transfers the requirement to conduct annual assessments of ICBs from NHS England to the Secretary of State and focuses the assessment on the statutory functions of these organisations rather than a narrow list of duties. Currently, the position is that NHS England assesses ICBs annually, using data and local insight to review their performance against their functions, including a list of duties prescribed by the current legislation. The results are published online and they inform the oversight relationship between NHS England and each ICB. However, this list of duties forms a static list of requirements which are already part of the ICBs’ statutory functions. Performance assessments need to adapt to the evolving role of ICBs as strategic commissioners, and evening out the focus across all ICB duties supports that, making assessment more flexible and meaningful as ICBs adapt.
These clauses enable the Secretary of State to support the system, respond to unforeseen challenges and uphold the standards that patients expect and deserve, while ensuring that we have fairness and impartiality at the heart of the National Health Service.
My Lords, I thank all noble Lords who have taken part in this revealing debate on the powers of direction of the Secretary of State. What the debate has drawn out is that it is not as clear-cut as the Minister suggests, and accountability is not the same as having the right to make unfettered decisions about the health service based on nearly every clinical decision or every finance decision in a locality.
Throughout the health service, day by day, many decisions are made for which the Secretary of State is accountable. I do not think any noble Lord is asking that the Secretary of State should not be accountable; it is right that they are, and it is within the accountability framework of the NHS. The issue that noble Lords have raised is what powers the Secretary of State should have over the day-to-day running of health services at a local level. It appears from what some noble Lords have said—the noble Lord, Lord Stevens, the noble Baronesses, Lady Manzoor and Lady Bennett, and the noble Earl, Lord Howe—that in the Bill those powers of direction may be too concentrated in the Secretary of State’s hands. I think we will come back to this on Report. The point raised by the noble Lord, Lord Patel, about clinical expertise being drawn on to make the Secretary of State come up with clinically sound decisions, is really important.
I note that, once they are a Secretary of State or a Minister in the Department of Health, nearly everybody who has been in the department—apart from the noble Earl, Lord Howe—wants the powers. I believe that the power to make the strategic direction of the health service, and to be accountable for that, is the Secretary of State’s, and the power to intervene in an emergency or in unusual circumstances should remain with the Secretary of State. To use the Minister’s point, the intention is not to micromanage but to use the powers sparingly. It is very good to hear that that is the role of the present Government. But, as the noble Lord, Lord Stevens, pointed out, a different Government with a different political stance will be making important decisions that could potentially have an effect on clinical access to services, as well as on where certain services are. I do not think the Minister has answered on that balance to many noble Lords’ satisfaction. We will therefore potentially come back to this on Report, but at this moment I beg leave to withdraw my amendment.
My Lords, it is quite a pleasure to follow the noble Lord, Lord Stevens, who asks some important questions about the transparency of the accountability mechanism—particularly since the whole reason for abolishing NHS England was to stop it being a stand-alone body in the department. As he has pointed out, we are abolishing a quango to set up a brand new quango. I look forward to the Minister’s answers on what the accountability mechanism will be if the CQC makes findings into maternity services in Norfolk.
I thank the noble Earl, Lord Howe, for these amendments. We made our position clear in the last group. We do not think that the general power in Clause 11 should exist in its present form, and in the last group we tabled a probing amendment with an alternative based on outcomes. However, if the Government insist on this, Parliament and the public should expect at least what these three amendments offer: a reason, a test and a record of those decisions.
Under the Bill, when the Secretary of State gives a direction under Clauses 8 or 11, they must publish it as soon as “reasonably practicable”. That is all. There is no reason, no duty to consult and nothing on how long it lasts or what it costs. The department’s memorandum to the Delegated Powers and Regulatory Reform Committee confirmed that there is no parliamentary procedure. On Clause 8, the memorandum says that directions avoid taking up “valuable parliamentary time” and that, unlike with voluntary delegation, a directed ICB would be “legally obliged” to carry out that function. It also says that publication means that the power is “used transparently”. Publishing an instruction is not transparency; explaining it would be the transparency that is required.
The Bill already accepts this. Under new Section 14Z62A, the Secretary of State must publish their reasons when they intervene in a board that is failing. A board in significant failure is told why; a board doing perfectly well which is directed under the general power—we should remember that this is a new power to direct an ICB that is not in any way underperforming—is not given a reason why the Secretary of State has decided to intervene. The Government cannot say that giving reasons is impractical when they require it a few lines further on in the Bill.
First, on the reason, the amendments to Clauses 8 and 11 would require a statement within seven working days on the function concerned, the reasons, how long the direction lasts, when it will be reviewed, its financial and operational effects, its effect on the ICB’s local population and who is responsible for what, which is absolutely vital for accountability. The Clause 11 amendment goes further. When subsection (3) is used and a board is made to act without forming its own opinion, the Secretary of State would have to say what opinion they formed and why, and why the board should not be able to form its own. This also matters for money. Clause 8 says that the Secretary of State may make payments, whereas Clause 11 says nothing about funding at all. A direction with no funding moves a cost from Whitehall to local services, and those affected deserve to see that reason.
Secondly, on the test, the memorandum says that directions are needed
“to respond to emerging situations”,
which is absolutely fine, and to secure nationally consistent standards. This amendment would stop neither: proposed new subsection (3D) would let the Secretary of State act first and consult afterwards where there is an urgent risk, with a decision on the direction within 28 days.
Proposed new subsection (3A)(c) expressly counts the benefits of consistency. It simply asks whether guidance, agreement or existing oversight would do the job and whether the direction is necessary and proportionate. It would also require the ICB to be consulted. If the Minister says, as I expect she may, that Ministers intend to act in this way, there is nothing to lose by saying so in the Bill. The Health Foundation has asked Ministers to set out safeguards for how the powers will be used, but we are still waiting for those safeguards and a full explanation.
Thirdly, in relation to the record, the proposed new clause after Clause 22 would put each direction in the board’s annual report: what has changed, what it cost, what risk the ICB warned about, and where responsibility lay. Under Clause 11, an ICB can be directed and, under Clause 21, is assessed on how well it has discharged its functions. Under new Section 14Z62A, failure includes failing to act
“consistently with what the Secretary of State considers to be the interests of the health service”,
and the chief executive can be removed. A board could follow an instruction, see its performance suffer and then be held to account for the subsequent result. Clear responsibility protects the ICB and protects patients.
I will be honest about the limits. None of these amendments gives Parliament a vote. Statements would be published, not laid. The test rests on the Secretary of State being satisfied, and Clause 8 has no such test. There is also a burden: consulting every ICB on a national direction takes time. Some of the drafting needs tidying before Report, but the general principle is one to be welcomed. The Minister may well call this bureaucracy, but if the Secretary of State cannot say within seven working days why they have given a direction, how long it lasts, what it costs and who is responsible, the Secretary of State really needs to think about why that direction has been given in the first place.
I have two very quick questions for the Minister. If reasons are required for a failing board, why not for every board, including boards that are performing well? Most importantly, what happens when an ICB follows an intervention and a direction from a Secretary of State and clinical outcomes or finance get worse? What happens in those circumstances and who, ultimately, will be held responsible? A reason, a test and a record—that is not much to ask of the Secretary of State who is taking so much power. I look forward to the Minister’s replies.
My Lords, I am most grateful for this debate, particularly following on from the last group. I hope that noble Lords found that the previous group laid some helpful groundwork ahead of addressing Amendments 32, 37, 38 and 86 in relation to Clauses 8, 11 and 25. I am grateful to the noble Lord, Lord Kamall, for tabling Amendment 32, which was spoken to by the noble Earl, Lord Howe.
As I noted in the previous group, I share noble Lords’ commitment to transparency and to the appropriate use of directions. However—this applies to a number of the points that were raised—this needs to be balanced with some caution about overspecifying requirements in the Bill, given that that could well come at the cost of flexibility and speed, which I know noble Lords understand the need for. In some cases, the information required may not be relevant in terms of the amendment. I assure the noble Earl, Lord Howe, that it is currently standard practice for much of the information that is being asked for in the amendment to be included in directions issued by NHS England and the Secretary of State, where it is operationally relevant. I have no expectation that this will change in the future.
The duties of ICBs were raised by the noble Earl, Lord Howe. ICBs will continue to have a duty to commission a comprehensive health service except for those services that are commissioned by the Secretary of State as specialist, and the Secretary of State retains the duty to promote that service.
I would like just a bit more clarification, and for anyone listening to this debate, on this real issue of patient services and how we are going to improve them. So, are there the positive directions? I understand there will be special directions by the Secretary of State, which is totally understandable—it has always been the case, certainly in the last 30-odd years that I have been involved with the NHS in one form or another. If we are going to improve our NHS, we need duties regarding the outcomes. Is there any thinking on that? Sorry to push a bit further, but that is critical if we are looking to improve the NHS for patients.
There is no need for the noble Baroness to apologise; that is what we are seeking to do. The point here is that we are, by definition, confining our discussions to when things are going wrong or there are concerns. It is important to state that all the changes we are making and all the frameworks that are in place—the whole suite of measures—are there to ensure patient safety, the right outcomes and the right service to patients. In this discussion there is inevitably a greater focus on when things go wrong, but we are trying to ensure that things do not go wrong.
My Lords, many of us are struggling and asking quite basic questions because we still have not seen the operational model or the framework for how the new system will work. Can the Minister give a commitment that, before Report, the operational model will be made available to noble Lords? If not, this is becoming a bit like trying to find your way through a maze while blindfolded. It really is difficult, and that operational model is vital for us to make legislation and help the Government improve it, which is in the interests of patients and the system as a whole.
I will always make available as much information as possible. Some of the core of our discussion is around what is appropriate to be in the Bill and what is not. It would be unusual to have the detail of an operational model in the Bill—which the noble Lord is not quite suggesting. However, I can certainly undertake to give as much information as possible.
My Lords, I am grateful to all noble Lords who have taken part in the debate on this group of amendments and for their insightful contributions. I am particularly grateful to the noble Lord, Lord Scriven, for his very helpful comments. As I mentioned in my opening speech, these amendments are intended to press the Government to address the key distinction between ministerial direction and local direction that the Bill has yet clearly to define, and to tease out more on the operational model, as we have just heard.
I thank the Minister for her reply, but I shall need to reflect carefully on her assertion that no explicit threshold on the use of the powers is appropriate or necessary. The noble Lord, Lord Stevens, set out a good hypothetical example of what could happen if amendments along the lines of those I have proposed are not adopted, especially Amendments 32 and 38 on transparency. The key questions are the ones so well expressed by the noble Lord, Lord Scriven, and, like him, I think that these are issues we shall wish to return to on Report. I am grateful for the briefing later this week to which the Minister has just referred, but I hope she will be open to working with us on these issues as we go forward. For now, I beg leave to withdraw the amendment.
My Lords, I am grateful for the debate that we have just had. With permission, I will address whether Clause 10 should stand part of the Bill, look at the amendments to it and refer to those things together.
As a number of noble Lords have rightly emphasised, we are indeed committed to a National Health Service that is free at the point of use. Noble Lords will be very familiar with the changes that we are making to ensure that patients are at its core, and that they find that the system works around them, rather than them having to work around the system. We see that throughout the 10-year plan. For many years, this has included the provision of NHS-commissioned services by charities and the not-for-profit and independent sectors, as referred to by the noble Baroness, Lady Murphy, the noble Lord, Lord Kamall, and my noble friends Lady Nargund and Lord Hunt, to mention a few. The fact is that all these sectors make a valuable contribution to the health of the people whom we serve. We should acknowledge that, but I think we should also celebrate it.
Clause 10 prohibits the Secretary of State using their functions deliberately to shift the balance between types of providers. It strengthens and extends Section 12E of the National Health Service Act 2006 to any health service function of the Secretary of State and applies to all providers, regardless of legal form—to answer the point raised by the noble Lord, Lord Kamall. The clause does not enable privatisation or nationalisation by the front door, the back door, the side door or indeed any door that we can think about. It is a general prohibition, with one exception: where the Secretary of State considers that to act differently is in the interests of the health service.
As to why we need that, currently under Section 12E, a Minister who sees a service failing and concludes that bringing it into the NHS is in the interests of the health service could not act. Equally, Ministers could not deliberately bring in charitable or independent providers to end a risky overreliance on a single NHS trust; nor could they see an entire sector dependent on a few external providers and choose to build more public capacity for the long term—something that noble Lords rightly would encourage—because such purposes are always prohibited, even though the outcomes can be beneficial.
Clause 10 enables Ministers to act when the interests of the health service require it. We expect Parliament to hold Ministers to account in doing so. I say to the noble Lord, Lord Stevens, and my noble friend Lord Hunt that Ministers, in their duty to promote a comprehensive health service, have a duty to act reasonably and rationally and, as I say, to be held to account for doing so.
The noble Lord, Lord Patel of Bradford—
I am trying to follow very closely what the Minister is saying. Am I right to take it from what she said that under Clause 10, an acute hospital trust could be moved to the private sector if the Secretary of State decided that that was in the best interests of the health service? Is that possible?
At the risk of repeating myself, as I have said, the judgment is about acting reasonably and rationally and about whether it was fulfilling its duty. It would also be—I know that I am repeating myself, but it bears doing so—accountable to Parliament for its decision.
The noble Lord, Lord Patel of Bradford, raised a question—
If the Secretary of State was acting under Clause 11 powers, Parliament would not have knowledge of that or any say on it. Does the Minister agree that that would be a correct interpretation of Clause 11 being used to bring about a change in public/private provision in Clause 10?
I am not sure that I can answer that right now, but I will certainly review the various clauses and come back on that point.
The noble Lord, Lord Patel of Bradford, raised a point about publishing reasons where an exception is made. I will look at that because, as he knows, we are very much committed to transparency.
I turn to the amendments from the noble Baroness, Lady Coffey, the noble Lord, Lord Kamall, and the noble Earl, Lord Howe, which I will discuss together. The phrase
“the interests of the health service”
reflects the Section 1 duty to the health of all people in England—both those currently using the NHS and those who might want to use it in the future. That said, I understand the points noble Lords are making and, as with all things, I will certainly look at them. But we believe that substituting the phrase so that the test may be used in the interests only of patients, as spoken to by the noble Lord, Lord Kamall, is a narrower approach that risks excluding the potential benefits to the service over time, and it excludes the interests of people who are not currently patients—which I know is not the noble Lord’s intention.
I would also caution against using an additional requirement that exceptional action must be
“necessary to improve patient outcomes”.
This might prevent the rescue of a failing service, given that it relates to improving, and not stabilising, services. For example, if a dialysis provider serving a large area failed, stepping in would clearly be necessary to keep treatment going, before any action to improve it. It therefore risks failing the proposed test at a time when decisive action is needed.
Surely stepping in to continue that dialysis service is in the interests of patients.
It is, and that is why I said I understand the point that noble Lords are making. We are not talking about the interests of the health service for the interests of the health service; it is there to promote the right outcomes for patients and their interests, too. That is why I acknowledged the points that the noble Lord and others made.
Baroness Nargund (Lab)
I would like some reassurance about making sure that the private sector does not offer any additional treatment at additional cost to NHS patients—it tends to happen in the IVF sector. When there is a block contract for NHS patients in the private sector, they may advise patients to have add-ons to get them to pay extra. Can the Government make sure that add-ons are not offered to patients with additional costs when they are NHS referrals?
Baroness Nargund (Lab)
Sorry, I must declare an interest: I am an authority member of the Human Fertilisation and Embryology Authority.
I would not wish to stop any noble Lord from declaring their interest, so I am sorry that I stood up too quickly.
My noble friend speaks to the point of the importance of proper commissioning by ICBs, drawing lines around what is provided and how they performance-manage all their providers. I will certainly be aware of the point that she makes.
The amendment of which we were speaking would mean that a service that served patients well but could in principle be provided publicly would have to go, while one that served them poorly but could not be replaced by public provision would remain, and I do not think any of us would want to see that.
I recognise that there are a range of opinions and disagreements about provision in the health service and how it should be organised, but, as I mentioned earlier, we are focused on being pragmatic, providing fairness and improving access and quality for patients. We are not in favour of favouring one form of provider over another for ideological reasons, and I am glad that a number of noble Lords share that feeling.
Just to be helpful, will the Minister write to the Committee before Report explaining the reason for Clause 10? I am not sure whether other noble Lords were in the same position as I was, but I did not understand and was not convinced as to why it was required, even after the Minister explained. Could she give real, practical examples of why the clause is required, based on the 2006 Act not allowing the Secretary of State the powers to make the provision between private and public that is required to improve patient care in a particular area? That would be helpful, I feel.
My Lords, I thank all noble Lords who have taken part in this fascinating and important debate, and I thank the Minister for her response.
The noble Baroness, Lady Coffey, said she thought I would be alone in my views, but we have heard from different quarters around your Lordships’ House expressions of concern about the destructive impact of markets and tendering on the NHS; the noble Lord, Lord Hunt, said so in his speech, and indeed he is nodding now. There is good evidence that the views of your Lordships’ House do not reflect the views of the public. I point noble Lords particularly to a study in Social Theory & Health in 2022, which I believe is the only time there has been an open-ended, representative survey of UK citizens about their view of privatisation. Lots of basic questions have been asked, such as “Do you think privatisation is a bad thing?”, but I think that is the only time the question has been asked: why do people think that? The largest single reason was the extraction of profits from NHS services. There is strong public resistance to that, and noble Lords should bear that in mind. The public see clearly that money that should be going to services is going to profits instead, and that is what my group of amendments seeks to address.
We have Committee stage for a reason, to probe amendments, and many noble Lords have probed at mine. To reassure the noble Baroness, Lady Thornton, and others, I certainly need to look at the wording of this. When I was talking about public and private, by “private” I was referring to for-profit providers. I reassure the noble Lord, Lord Scriven, and others that there is no intention here to do away with hospice provision, charity provision and not-for-profit provision. These amendments are all aimed at the for-profit sector.
My Lords, I am most grateful for the constructive amendments that have been tabled on cancer services. Noble Lords will know that we take this issue very seriously, as evidenced by our national cancer plan, which sets out very clear priorities to transform cancer care and outcomes over the next 10 years. In addition to that, I say to the noble Lord, Lord Evans, that what is being spoken about now strikes at the very core of the Health Bill and the reasons we are taking the actions that we are to be able to improve the situation still further. I recognise the impact of cancer on many noble Lords, either directly or indirectly, and I thank them for bringing their personal experience to the debate. It is important not just within this Chamber but to so many people outside, where one in two will be affected by cancer.
I will address some of the amendments before us. On Amendment 41, I can assure the noble Baroness, Lady Pidgeon, of our commitment to improving cancer outcomes. The noble Lord, Lord Stevens, welcomed our national cancer plan, which sets out an ambition to increase five-year survival to 75% by 2035, which will save an estimated 320,000 more lives over the next decade. The current law requires the NHS mandate to include cancer outcome objectives, which NHS England must prioritise over other cancer-specific objectives. With the abolition of NHS England that mechanism will no longer be needed, but that is because our focus on prioritising cancer outcomes remains. I hope that that is the start of a reassurance to my noble friend Lady Morgan, who raised this point, and rightly so, at Second Reading.
The plan provides a clear programme for delivery, supported by annual reporting on progress against key measures and targets. Last month, we confirmed a new independent National Cancer Board that will help scrutinise our progress—progress that the noble Lord, Lord Patel, rightly seeks—and, importantly, will ensure that the voice of cancer patients is heard. I know my noble friend Lady Ritchie will particularly welcome that. We therefore consider an additional statutory duty to prioritise cancer outcome objectives unnecessary, in terms of legislation. Our priority, as the noble Lord, Lord Patel, spoke to, is to deliver the commitments of the plan.
Amendment 217 addresses research into cancers with the lowest survival rate. We invest around £1.8 billion each year on research through the National Institute for Health and Care Research. Cancer is a major area of expenditure, standing at £141.6 million in 2024-25, which reflects its high priority.
We recognise that research into all cancers—a point that a number of noble Lords have raised—including those with the lowest survival rate, is a key priority. Research is funded through open competition and peer review to ensure that the highest-quality proposals—the ones that are most likely to deliver real impact for patients—are funded without imposing financial targets or limits. Our cancer plan includes a commitment to make progress on rare cancers one of the six key research priorities, to tackle stubbornly low survival rates. Our aim is to be in the top quartile across 28 countries for survival of 14 rare and less common cancers.
To the point made by my noble friend Lady Nargund, we are strengthening international research collaboration. For example, a joint call with the Japan Agency for Medical Research and Development opened just last month, to which the NIHR is committing a total of £2 million to support UK-based components. In respect of my noble friend’s question about pathways from MHRA and NICE trials to making treatments available, this is absolutely key. A new cancer trials accelerator will make the NHS the first-choice partner for cancer clinical trials.
I can confirm to the noble Baroness, Lady Finlay, that the DHSC still participates in and influences the EU cancer mission. I hope that noble Lords will appreciate that we very much see the importance of international work, both with our EU partners and beyond the EU.
My noble friend Lady Morgan seeks reassurance that there will be an appropriate and dynamic focus on improving participation in clinical trials. The answer to that is yes. We are also looking into options to contact patients with rare cancers to offer them the opportunity to be part of clinical trials, through a tailored version of the Be Part of Research service. My noble friend will also know the demanding targets we have set ourselves in terms of setting up clinical trials.
Turning to Amendment 228, improving performance against cancer waiting standards is absolutely key. There has been year on year progress with waiting times, but I would be the first to admit that there is some way to go. To my noble friend Lady Royall, as well as the noble Lord, Lord Evans, I can say that cancer waiting time targets, including the 62-day referral to treatment target, are not set at 100% for several reasons. They include patient choice, clinical guidelines and the reality and complexity of diagnosis and treatment planning, which mean that not every patient can or should be treated within the waiting time standard.
Change, including improvements to parts of the cancer pathway and tackling variation in performance across trusts, which is something I know is of concern to noble Lords, will not be delivered overnight, but the national cancer plan sets out the concrete and measurable actions in how we are going to get there. I assure the Committee that the plan makes a clear commitment to meet all the cancer waiting time standards. We will go further, reviewing them once they have been met, to consider whether they should be strengthened. In other words, it will not be case of job done and move on; we will review what more we can do.
I am grateful to my noble friend, Lady Royall, for bringing Amendment 233 before the Committee today. The Government are determined to improve outcomes for men with prostate cancer, and we have partnered with Prostate Cancer UK on the £60 million TRANSFORM trial to find the best way to screen men for prostate cancer. That was something the noble Lord, Lord Evans, raised.
However, as noble Lords will be aware, the case for an early detection programme has recently been considered through the UK National Screening Committee’s established evidence review process. For men without symptoms, early detection would, in practice, amount to screening. The committee therefore recommended screening only where the evidence shows that the benefits outweigh the harms. With prostate cancer, earlier detection is not always better. Many prostate cancers are slow growing and may never cause harm, while PSA testing cannot reliably distinguish these from aggressive cancers. Screening can therefore sometimes lead to overdiagnosis and unnecessary treatment, with potentially life-changing consequences, so we continue to be guided by the evidence.
My noble friend Lady Royall also asked about further inclusion. Prostate Cancer UK is using local government engagement grants to ensure that local organisations that work in Black communities can support recruitment to the trial, which was the point she was concerned about, and can also spread awareness of the trial.
Turning to Amendments 247 and 250, tabled by the noble Baroness, Lady Finlay, the Government agree that genomic testing should be timely, equitable and fully integrated into cancer care. The cancer plan commits to providing genomic testing to every cancer patient who would benefit from one within a clinically relevant timeframe, so that the results can inform treatment decisions.
Our focus is on ensuring that the NHS Genomic Medicine Service works consistently for patients and ensures that results inform treatment. To the point about workforce, we will create 5,000 learning and training opportunities each year, including opportunities to develop knowledge of emerging technologies, such as genomics.
At the same time, NHS England is improving the links between pathology and genomics, expanding molecular profiling and developing national digital arrangements for requesting and tracking tests. These improvements are best taken forward through NHS commissioning and service arrangements, in our view, rather than through a broad statutory duty, so there can be adaption as clinical evidence and technology develops. I was glad to hear the noble Lord, Lord Patel, welcome the establishment of the genomic hubs and the work they do.
Finally, I turn to Amendment 250. We share the ambition in terms of radiotherapy, and patients should have timely access to modern, effective treatment wherever they live. The noble Lord, Lord Tarassenko, spoke to the points on radiotherapy. However, it is our view that a specific duty for the Secretary of State for one treatment in particular would set a precedent and cut across the devolved models in which local systems and cancer alliances are expected to deliver.
My Lords, I am most grateful to the Minister for her comprehensive response to the amendments, including mine. Can she assure us that the data that she spoke about will now be supplied directly to OECD as well, so that we will be able to resume international comparisons, and that it will include quality of life data as well as simply survival data, because survival data itself may be misleading? In among the quality of life, of course, there is the impact of the family reported outcome measures as well, which can go along with that and be very informative. Unless all the data, including genomics data, is linked to demographic data, we will not get much further in untangling some of the underlying causes, which may be environmental, of the increase in malignancies that we see in the younger population. There has been an upward creep, but it is definitely there.
I will need to check on the first point that the noble Baroness asked me about—the supply of information—but I will gladly write to her once I have looked at it. I absolutely agree with the point that she makes about data being one thing, but it is only as good as the use you can put it to. We seek to collect the right data for the right purpose; in other words, to improve outcomes.
Baroness Pidgeon (LD)
I thank noble Lords for the quality of the debate on this group. I particularly thank the noble Baroness, Lady Ritchie, for sharing such a personal story earlier.
I am glad to hear that the Government are committed to improving cancer outcomes, but I still have questions. Given that it was in the 2022 Act, and part of that Bill, where is the annual mandate that was set out for NHS England going to sit now? Perhaps the Minister can write to noble Lords setting out how that will not be lost, just to assure us. It is not just noble Lords here who are concerned; the sector and charities are very concerned that it will be lost. It was in a Bill before, so let us try to understand why the Government do not think it is needed now. But given the response we have had and the debate, I beg leave to withdraw my amendment.
My Lords, I am most grateful to noble Lords for bringing the important matter of social care before the Committee. I am sure that the noble Lord, Lord Kamall, knows that, as much as I would love to give him every dot and comma, there is a reason why that is not possible.
Amendments 42 and 44, tabled by the noble Baroness, Lady Tyler of Enfield, and spoken to by the noble Baroness, Lady Pidgeon, my noble friend Lady Pitkeathley and the noble Lord, Lord Scriven, relate to the Secretary of State’s role in respect of social care. I think we could not have been clearer—we have discussed the role of the Prime Minister today—about the strength of national leadership that is required. The noble Baroness, Lady Pidgeon, acknowledged that the Prime Minister committed to establishing a national care service in the next Parliament to sit alongside our National Health Service and to be linked with it.
On the matter of the amendments, the reality is—at the risk of sounding simply pragmatic in legislative terms, but I will take that risk—that adult social care already has its own statutory framework under the Care Act 2014, which is separate to this legislation. That Act provides legal duties on local authorities for the provision of care and support in England and gives the Secretary of State overarching supervisory and intervention responsibilities.
As we develop our plans for national care services, that is where we will consider the responsibilities, the accountabilities and where they will operate—to refer to some of the questions that the noble Lord, Lord Scriven, raised. As I have indicated, although they are linked, health and adult social care have distinct roles—complementary, yes, but distinct—and each is crucial in its own right to providing care for our citizens, as the noble Baroness, Lady Barker, described.
As plans for reform develop—I will come back to the point about the noble Baroness, Lady Casey—we will work with partners and stakeholders to consider how we can do exactly what noble Lords are rightly asking for: consider how accountability, funding flows and responsibilities can be clear and more consistent. But my noble friend Lady Thornton described this as a Bill of moving parts, which was a good description. On the basis that we are talking about moving parts, nailing down one before all the relevant parts have been dealt with will get us into more difficulty. Frustrating it may be, but that is the honest reality.
Following that logic, why are we nailing this part down before the others are ready?
The reason is that we consider that these parts can sit on their own, and the Bill allows us to look forward too. It would not be acceptable—the noble Lord is not suggesting this—if we stopped all our work while we waited until everything was in place. Although my noble friend is right, I cannot really remember a time when we did not have a lot moving parts—or perhaps we had some parts that should have been moving more but were not, to be more precise.
I go back to the commission on adult social care of the noble Baroness, Lady Casey, about which the noble Lord, Lord Kamall, asked further questions. First, its work has already been brought forward by a year by Prime Minister Andy Burnham. We have already actioned the initial recommendations. As a reminder, we worked at pace on that and I emphasise that the review is independent, which by definition means that we are allowing the noble Baroness, Lady Casey, to do her work.
The other point, which has been absent in previous iterations of attempts at this work, is that we are committed to making this an all-party answer that can survive Governments. All Governments previously have failed to do that, and this is too big and too important an issue to fail to secure that backing. The early recommendations that we put straight into place were—oh, I see the noble Lord standing up; I thank him for being very specific.
I want to ask specifically what that cross-party approach means. For example, many noble Lords on all Benches have spoken about social care in this debate and at other times. There is great expertise in this House. When will they—including me, if I am considered worthy enough of “expertise”—be engaged in this cross-party approach?
How might I put it? That will be down to the appropriate levels of the parties to decide who is included. However, I can say to noble Lords that, after the contributions that have been made not just in this Chamber but in the reports that have been made, I have been a number one advocate to my ministerial colleagues, including Secretaries of State, of looking to the expertise in this House—because the work that has gone on and continues to go on is extremely significant. The noble Lord can be assured of that.
I do not think that I referred to what the earlier recommendations were from the noble Baroness, Lady Casey, but, if I did, forgive the repetition. On dementia, adult safeguarding and motor neurone disease, we are also driving significant progress through £4.6 billion of additional funding available for adult social care in 2028-29, compared to 2025-26, which includes £500 million for the first ever fair pay agreement for care workers. We have said we will establish a national care service in the next Parliament, providing free personal care for older people.
On funding, I can only repeat what the Prime Minister and Chancellor have said, which is that it will be fully funded and made possible through adjusting the triple lock from 2030. I give the confirmation that we will not borrow to pay for reform, and we will continue to meet our fiscal rules. I think there is a proper conversation to be had, as the noble Lord, Lord Kamall, said, on the choices and trade-offs necessary to deliver a system that can work for everyone into the long term, as well as the immediate. That is exactly why the Prime Minister is continuing cross-party talks to achieve this. The other thing I would emphasise is that we are determined to deliver rapid progress on social care, and we want to work, and are working, in partnership with those who draw on care and support.
On Amendment 180, tabled by the noble Lord, Lord Kamall, as I have already indicated, I do not believe that we should pre-empt the commission’s recommendations on fundamental reform questions ahead of building a public consensus as well as a political one. We should not legislate for an implementation plan within a fixed timeframe.
With regard to a national care service work plan, the review from the noble Baroness, Lady Casey, will have important implications for the shape and skills of the future adult social care workforce. Noble Lords will recall that this Government have committed to a long-term workforce plan for adult social care, which will therefore need to be linked with the outcome of that review. I certainly welcome that workforce plan.
On the amendment on dementia tabled by the noble my noble friend Lady Ritchie, and spoken to by a number of noble Lords, including the noble Lord, Lord Weir, dementia, as with social care, touches the lives of many in and outside this Chamber. That is why I am glad that my noble friend welcomes the development of the modern service framework for frailty and dementia. We plan to publish the full MSF by the end of this calendar year, which was recommended by the noble Baroness, Lady Casey. The framework will set new national standards. However, until we finalise those standards, I think it would be premature to propose introducing a new annual report. The reason for that is that it would lack the necessary measurable metrics to support the meaningful analysis that I know noble Lords are looking for, as indeed I am. It is not about denying the role of data; it is about the process. We are looking at options for how we can reduce waiting times and improve diagnostics and care, including reviewing targets and metrics and, importantly, to the points raised by noble Lords, data. We will seek to develop a list of best evidenced interventions following analysis of this area.
Some of the data requested and referred to in the amendment is already available through the NHS or provided by charity partners. A new report would, unfortunately, be something of a duplication of this work. We must also have some regard to the demands of additional data collection. The assessment is that the additional data collection that would be required for this work would be somewhat onerous and would distract from the core task of improving dementia care. That said, I understand why noble Lords are raising this, and I can assure them that the points they have made will be considered as we look at our development of the modern service framework.
My Lords, I am grateful for the contributions to the debate today and for the amendments that gave rise to the debate. Primary care is a key part of our health service, as we have heard. In view of the time, I am going to address directly the amendments and some of the comments made.
Amendment 218 was tabled by the noble Baroness, Lady Pidgeon. We recognise the importance of timely access to general practice, particularly when patients need urgent care. However, it is the case that not every patient will need an appointment within seven days, although I understand the intent, because there are a number of patients who seek to book routine appointments in advance. Where a doctor considers care clinically urgent, patients should be seen that day, and we have made changes to the GP contract to require that urgent requests be handled the same day. In August this year, nearly 78% of such requests were handled the same day.
I want to correct some of the representations made by the noble Earl, Lord Howe, as I have done previously when we have been debating this Bill. As of August 2026, there were more than 2,600 more GPs compared to July 2024. We have introduced a practice-level GP reimbursement scheme, worth £292 million, that allows practices to hire additional GPs or fund extra GP sessions with existing GPs. Our absolute intent, as I know is the noble Earl’s, is to improve access. We want to support GPs, improve patient satisfaction and boost capacity—something we are all signed up to.
On Amendment 43, tabled by the noble Baroness, Lady Neville-Rolfe, and spoken to by the noble Baronesses, Lady Finlay and Lady Gerada, the Government support the principle—if that could be regarded as a word of comfort—as sought by the noble Earl, Lord Howe. However, we regard the amendment as unnecessary because existing contractual and operational arrangements already strengthen continuity, which is the key point in this. That includes named GPs and team-based continuity in hospitals. The noble Baroness, Lady Gerada, asked whether there was a possibility of the splintering of community services through hubs. I would say that neighbourhood health provides the core framework that brings it all together into a single model very much focused on improving access and experience, which is at the core of all that the noble Baroness rightly seeks.
I turn to Amendments 63, 108, 109 and 110 from the noble Baroness, Lady Janke, about pharmacy care. I agree with all the comments about the vital contribution that pharmacies and their staff provide to patient care. I also acknowledge that, where a provider, particularly a larger chain, fails to meet NHS terms of service, the consequences can be significant for patients, communities and staff. The Bill will give ICBs responsibility for pharmaceutical services, including monitoring compliance and enforcing NHS terms of service. We are also streamlining appeals to ensure that we can resolve disputes more quickly. Where there is provider failure, our priority is to maintain the continuity of services for patients. ICBs can issue remedial and breach notices, remove contractors following repeated breaches and, with professional regulators, suspend providers where there are serious concerns putting patients or the public at risk.
I say to the noble Baroness, Lady Pidgeon, that the Bill strengthens arrangements to ensure continued access to pharmaceutical services and allows the Secretary of State and ICBs to support new providers taking over pharmacy premises, including financially. We of course sympathise with staff affected by provider failure, but the reality is that, as we have discussed on a number of occasions, community pharmacies are independent businesses responsible for employing and paying staff. Existing employment and insolvency law already protects employees, as in other sectors. Therefore, a separate regime, as suggested, would not be appropriate.
I feel that Amendment 64 would limit flexibility to balance rural access with wider patient and pharmacy needs. The distribution of pharmacy funding is determined through an established national process. All pharmacies receive the same NHS service fees, while eligible isolated pharmacies receive additional pharmacy access scheme funding.
I turn to Amendments 60 and 62 from the noble Lord, Lord Scriven. We recognise that people with learning disabilities are more likely to experience sight problems and may face additional barriers to eye care, exactly as the noble Lord described. He has already referenced this, but I emphasise that free NHS sight tests are already available to eligible groups, including people at increased risk of specified eye disease. Adults with learning disabilities may qualify through these routes, including via the NHS low income scheme, but there are no plans to review eligibility, as he sought.
Community optical practices also already provide services with reasonable adjustments where needed. Those who are unable to attend unaccompanied, and who are eligible because of illness or disability, may receive NHS domiciliary sight tests. As the noble Lord rightly said, children and young people with learning disabilities or autism can receive free eye tests in special educational settings, where locally commissioned. I heard the noble Lord talk about difference in provision, and I also thought I heard him acknowledge the potential for the Bill perhaps to assist in that regard.
On Amendment 61 from the noble Baroness, Lady Pidgeon, I understand the concerns that the Bill could lead to variation in eligibility for NHS sight tests, the scope of the service or the fees payable. However, ICBs already commission primary ophthalmic services under nationally set contractual terms, so eligibility and service scope are set nationally, and fees are set through national direction. The Bill does not alter the national framework or how eligible patients access sight tests.
On Amendment 61A by the noble Baroness, Lady Gerada, local planning begins with joint strategic needs assessments, through which health and well-being boards assess local population health and care needs. These assessments will then inform locally led neighbourhood health plans, which set out the approach to meeting the identified needs. ICBs, in their role as strategic commissioners of local health services, including eye care services, will focus on ensuring the best value in securing services and improving population health, reducing inequalities and improving access to high-quality services. Given these existing arrangements, we do not believe it necessary to prescribe service-specific reporting requirements in primary legislation.
My Lords, this has been a constructive debate. I am grateful for the convincing support of the noble Baroness, Lady Gerada, and my noble friend Lord Howe for an amendment of the kind that I have proposed.
I thank the noble Baroness, Baroness Finlay of Llandaff, for her perspective and her comment about the non-verbal advantages of continuity of care, which very much echoes with me. I remember my husband being saved by a perceptive GP when he had come out of an operation. I heard what the Minister said, and I thank her for it, but we need to do more on continuity of care as well as on continuity of services, so I reserve the right to return to this issue on Report.
As it is late, I will not delay the Committee on the other amendments, which have been well articulated by the noble Lord, Lord Scriven, and the noble Baronesses, Lady Janke and Lady Pidgeon. I agree with the noble Baroness, Lady Janke, that pharmacists can play a larger part in our National Health Service. I also agree with the noble Baroness, Lady Gerada, about the postcode lottery of eyecare. That is a concern, and the Minister may recall from our earlier debates that I thought it could perhaps be improved by the better use of the independent sector and community eyecare. For now, though, the time is late and I beg leave to withdraw my amendment.